Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

A model for homeopathic remedy effects: low dose nanoparticles, allostatic cross-adaptation, and time-dependent sensitization in a complex adaptive system



This paper proposes a novel model for homeopathic remedy action on living systems. Research indicates that homeopathic remedies (a) contain measurable source and silica nanoparticles heterogeneously dispersed in colloidal solution; (b) act by modulating biological function of the allostatic stress response network (c) evoke biphasic actions on living systems via organism-dependent adaptive and endogenously amplified effects; (d) improve systemic resilience.


The proposed active components of homeopathic remedies are nanoparticles of source substance in water-based colloidal solution, not bulk-form drugs. Nanoparticles have unique biological and physico-chemical properties, including increased catalytic reactivity, protein and DNA adsorption, bioavailability, dose-sparing, electromagnetic, and quantum effects different from bulk-form materials. Trituration and/or liquid succussions during classical remedy preparation create “top-down” nanostructures. Plants can biosynthesize remedy-templated silica nanostructures. Nanoparticles stimulate hormesis, a beneficial low-dose adaptive response. Homeopathic remedies prescribed in low doses spaced intermittently over time act as biological signals that stimulate the organism’s allostatic biological stress response network, evoking nonlinear modulatory, self-organizing change. Potential mechanisms include time-dependent sensitization (TDS), a type of adaptive plasticity/metaplasticity involving progressive amplification of host responses, which reverse direction and oscillate at physiological limits. To mobilize hormesis and TDS, the remedy must be appraised as a salient, but low level, novel threat, stressor, or homeostatic disruption for the whole organism. Silica nanoparticles adsorb remedy source and amplify effects. Properly-timed remedy dosing elicits disease-primed compensatory reversal in direction of maladaptive dynamics of the allostatic network, thus promoting resilience and recovery from disease.


Homeopathic remedies are proposed as source nanoparticles that mobilize hormesis and time-dependent sensitization via non-pharmacological effects on specific biological adaptive and amplification mechanisms. The nanoparticle nature of remedies would distinguish them from conventional bulk drugs in structure, morphology, and functional properties. Outcomes would depend upon the ability of the organism to respond to the remedy as a novel stressor or heterotypic biological threat, initiating reversals of cumulative, cross-adapted biological maladaptations underlying disease in the allostatic stress response network. Systemic resilience would improve. This model provides a foundation for theory-driven research on the role of nanomaterials in living systems, mechanisms of homeopathic remedy actions and translational uses in nanomedicine.

Peer Review reports


The purpose of this paper is to propose a model that explains how homeopathic remedies act on living systems (Figure 1). Basic science research suggests that classically-prepared homeopathic remedies (A) contain measurable source nanoparticles (NPs) and/or silica nanoparticles with adsorbed source materials [14] which are heterogeneously dispersed in colloidal solution; (B) act by modulating biological function of the allostatic stress response network [5, 6], including cytokines, oxidative stress and heat shock proteins [7, 8], as well as immune, endocrine, metabolic, autonomic and central nervous system functions [9, 10]; (C) evoke biphasic actions on the adaptive plasticity of living systems [1115] via organism-dependent, endogenously amplified, rather than agent-dependent pharmacological, effects [16]. The effects of homeopathic remedy nanoparticles involve state- and time-dependent adaptive changes [7, 8, 1720] within the complex adaptive organism [1922]. The main clinical outcome is (D) improvement in systemic resilience to future environmental stressors and recovery back to normal healthy homeostatic functioning [23]. Disease resolves as an indirect result of changing the system dynamics that had supported its original emergence [21, 22], rather than as a direct result of suppressing end organ symptoms.

Figure 1

Nano particle model for homeopathic remedy action: hormesis, allostatic cross-adaptation, and time-dependent sensitization of the nonlinear stress response mediator network. Global and local healing occur across the person as a self-organized complex adaptive system in response to the individualized remedy serving as personalized hormetic stressor, i.e., holistic nanomedicine: an exogenous nanoparticle stimulating self-amplified, bidirectional adaptive change (see text).

Other investigators have proposed a variety of theories for homeopathic remedy effects, e.g., persistent memory of unique water structures, water-ethanol clusters, epitaxy, and nanobubbles [2432], glass-derived silica crystals and structures [4], electromagnetic activities [33], biological signaling [9], quantum macro entanglement [34, 35], nonlinear dynamics of complex systems [13, 19, 20], stressor effects and hormesis [3638]. The current nanoparticle-cross adaptation-sensitization model incorporates and builds upon many conceptual points and empirical findings from this previous body of work, while offering an integrated, comprehensive synthesis for systematic testing [39].

Homeopathy is an over 200-year-old system of complementary and alternative medicine (CAM) developed by the German physician Samuel Hahnemann, MD. The field has a well-articulated practice theory [40], extensive case report-based clinical literature [41], high levels of patient satisfaction [42, 43], and a growing modern research base [44, 45]. Nonetheless, homeopathy has engendered some of the most intense skepticism within CAM, largely over the nature of its medicines (“remedies”). The classical process of manufacturing homeopathic medicines involves trituration in lactose and/or serial dilution in ethanol-water solutions and succussion (vigorous repeated cycles of shaking via hand or standardized mechanical arm pounding on a hard surface) in glass vials containing ethanol-water solutions [40]. Common dilution factors are 1 part source to 9 parts diluent (1/10, decimal, D or X potencies) and 1 part source to 99 parts diluent (1/100, centesimal or C potencies). Original bulk-form source materials are typically plant, mineral, or animal in nature.

Once dilution and trituration steps in lactose and/or succussions in liquid solvents begin, any low potency homeopathic remedy prepared above mother tinctures, i.e., 1X to 23X or 1C to 11C, should theoretically still contain bulk-form molecules of source material as well as source nanoparticles [3, 46]. In theory, repeated dilution steps leave progressively fewer and fewer molecules of bulk-form source material in a true solution, until eventually none should persist in solution diluted past Avogadro’s number (6 x 1023), i.e., potencies higher than 24X or 12C. Ordinary clinical chemical assays can at best find relatively low numbers of bulk-form source molecules, for remedies at low potencies and none at higher potencies. As a result, conventional medical scientists and chemists reject the plausibility of homeopathy because of the presumptive lack of sufficient bulk-form source material to exert a “usual” pharmacological dose–response effect. In typical clinical pharmacology, lower bulk-form “doses” should exert lesser effects, until there are no biological effects at all.

These points are seemingly valid, if the underlying assumptions are valid – i.e., that homeopathic medicines are ordinary, dissolved and diluted bulk-form chemical drugs in true solution that could only act pharmacologically [47] with linear dose–response relationships. However, the trituration and succussion procedures in classical homeopathic remedy preparation may actually be crude manual methods that generate “top down” nanoparticles of source material. Nanoparticles range in size from 1 nanometer (nm) on a side up to 1000 nm or more, though much nanoscience research focuses on special acquired properties of small nanoparticles below 100 nm [48]. Trituration with mortar and pestle is a manual method for mechanical grinding or milling, similar to ball milling used in modern nanotechnology [49, 50]. Like modern nanotechnology methods of microfluidization [51, 52], sonication [53, 54], and vortexing [55], manual succussions introduce intense turbulence, particle collisions, and shear forces into solution that break off smaller and smaller particles of remedy source material as well as silica from the walls of the glass containers or vials [1]. The combined impact of these mechanical nanosizing procedures [54] would be to modify the properties of the remedy [26, 30, 32], generating remedy source nanoparticles [2, 3], as well as silica crystals and amorphous nanoparticles [3, 4, 32].

Persistent remedy source nanoparticles have been demonstrated with high resolution types of electron microscopy in metal and plant homeopathic remedies prepared both below and above Avogadro’s number [2, 3]. Studies also report finding measurable amounts of nanosilica and its precursors in glassware-prepared remedies and other medicines [3, 4, 32, 56]. The types of glassware [56] (or polymer containers [1]), pH, temperature, amounts of agitation, and the ratio of ethanol to water solvent [57, 58] can further modify the specific sizes and properties of the resultant nanoparticles. Nanoparticles are different from bulk-form materials as a function of their small size, including acquired adsorptive [56, 59], electromagnetic, optical, thermal, and quantum properties [33, 48, 60, 61].

With their highly reactive and catalytic surfaces [48], NPs aggregate through self-assembly, and readily adsorb other nanoparticles and organic materials onto their surfaces, e.g., DNA, proteins, plant extracts or lactose [48, 60, 6268]. In addition to mechanical attrition methods, multiple studies have demonstrated that plant mother tinctures can biosynthesize metal (silver or gold) or silica (silicon dioxide) nanoparticles and structures via natural phytochemical reactions in vitro[64, 6972]. When plant herbal tinctures are used for biochemical synthesis of silver or gold metal nanoparticles from metal salt solutions, evidence indicates that the herb adsorbs onto the surfaces and modifies the sizes and properties of the resultant metal nanoparticles during this “green” manufacturing process [64, 69, 73]. The metal NPs then can convey plant-modified specific biological effects [64]. Such nanoparticles could augment and amplify the more direct, bulk herb-like properties for very low potency remedies made from ethanolic plant mother tinctures [46].

At higher liquid potencies, silica from the glass container walls released during succussions appears to be an important contributor to the generation of active homeopathic remedies [1, 3, 4, 32, 74]. Experimental data also show that nanosilica can self-assemble into 3-dimensional structures that can withstand drying, using DNA, proteins, or living cells as biological templates (a type of epitaxy) [71, 72, 7578]. The interaction and adsorption of specific remedy source with lactose and/or silica in the lowest homeopathic potencies such as 1C or 1X and the next few very low potencies in glass vials containing ethanol-water solutions would create remedy-specific lactose- [79] and/or silica-adsorbed “nanoseeds” for generating subsequent potencies [3, 64].

Once formed at lower potencies, remedy NPs and remedy source-modified nanosilica [64, 67, 78] could be capable of seeding regrowth or self-assembly of pre-formed silica nanostructures at higher potencies [4, 32, 71, 80]. Nanotechnologists regularly use silica in bottom up self assembly of specific nanostructures based on DNA, proteins, or other materials as epitaxial structural templates [67, 77]. Any involvement of silica [3] or other nanostructures [32] would occur in addition to the demonstrated physical transfer of detectable remedy source nanoparticles themselves during the serial dilutions into higher potencies [2]. Nanosilica would serve as a non-specific biological amplifier [81, 82], if present [1], as well as a vehicle for additional remedy-specific structural and/or electromagnetic information.

For instance, one type of amorphous nanosilica can retain memory of an electric- or magnetic-field induced orientation [83]. Previous studies have shown that some homeopathically-prepared materials can emit detectable electromagnetic signals [33]. Such signals could, along with the adsorbed and perhaps encapsulated remedy nanomaterial structures [65] and epitaxial processes [3, 24, 64, 71], thereby convey remedy-specific information in these multiple ways. The information could derive from lasting alterations in the electrical conductivity of nanosilica and other nanostructures. The process might take advantage of silicon’s semiconductor capabilities when “doped” with very small quantities of some inorganic or organic materials, i.e., from remedy source NPs in liquid potencies. However, since homeopathic remedies are often dried onto lactose pellets for storage and convenient transport, any model for homeopathy must also accommodate the need to retain the remedy-specific signal while dried and restore it upon clinical administration. Silica and protein nanostructures can survive drying [66, 77]. Lactose can absorb intact nanoparticles sprayed onto its surfaces [66].

Detection and study of these particles and proposed nanostructures present scientific challenges. Ordinary chemical assays and light microscopy cannot detect the nanoparticles, especially at higher potencies [84, 85]. Certain types of spectroscopy, e.g., Raman [24], but not always others, e.g., NMR [32, 86], can indirectly detect their presence in solution. Various physico-chemical methods can find indirect evidence from heat or light release by disrupting the dynamic structures that nanoparticles form in the solvent. High resolution imaging techniques [84, 87, 88], including atomic force microscopy, scanning electron microscopy, or transmission electron microscopy, can directly provide images of the actual presence of identifiable source nanoparticles in a given remedy [2, 3, 69]. Technological advances for characterizing single nanoparticles may also facilitate this type of research [88, 89]. With their increased bioavailability and reactivity, nanoparticles lower the doses of a drug, herb, nutriceutical, or antigen needed to produce clinical effects in medical applications, by orders of magnitude [63, 68, 90, 91].


Overview of the model

Three assumptions frame the discussion, and four principles provide the theoretical basis for this model.

The assumptions from the mainstream physiological literature are:

  1. (1)

    Human beings, animals, and plants are complex adaptive systems or interconnected self-organizing networks [23, 9294];

  2. (2)

    The allostatic stress response network of nervous, endocrine, immune, and metabolic pathways within the larger network of the organism is a hub that interacts with and adapts to environmental stressors [5, 95, 96]. Such stressors are any type of exogenous (or endogenous) stimulus that can disrupt homeostatic balance in the human being as an organism [5, 94].

  3. (3)

    Progressive allostatic overload of the adaptive capacity of the organism by higher intensity stressors leads over time to changes in functional set points and dynamic attractor patterns [10] that underlie the emergence of chronic disease. Disease manifests as unique complex, nonlinear, dynamical patterns of maladaptive function, determined by genetic, epigenetic, and lifestyle factors [5, 95].

There are four principles of the nanoparticle-allostatic cross-adaptation-sensitization (NPCAS) model that explain homeopathic remedy action:

  1. (A)

    Homeopathic remedies are highly reactive source and/or remedy-modified silica (or polymer) nanoparticles, not bulk-form drugs [2, 3];

  2. (B)

    Remedy nanoparticles stimulate a complex adaptive response in the organism that begins in the allostatic stress response network, with cascading indirect consequences over time across the entire self-organizing organism. The homeopathic simillimum (clinically optimal) remedy nanoparticles [16] serve as low level, but highly salient novel stressors, i.e., specific biological signals for the overall organism [9];

  3. (C)

    The adaptive plasticity processes that underlie the direction and magnitude of remedy effects on living systems involve nonlinear physiological phenomena such as hormesis, cross-adaptation, time-dependent sensitization and cross-sensitization/oscillation. As a low intensity stressor, remedy nanoparticles stimulate changes in the opposite direction to those of the higher intensity stressors that fostered the original development of disease [16, 97, 98]. The disease-related maladaptations prime the system [10, 39]. Then the correct remedy in low dose elicits reversal of direction of the maladapted responses.

  4. (D)

    The adaptive changes that the remedy evokes ultimately strengthen systemic resilience. The successfully treated individual can resist and rebound from subsequent challenges from higher intensity homeostatic disruptors of the organism as a complex network, at global and local levels of organizational scale [22].

In the context of medicine [99101] and complementary and alternative medicine (CAM) [13, 1922], researchers have previously detailed the evidence that living organisms are complex adaptive systems (CAS) or networks of interconnected, interregulated components. Other investigators have extensively addressed the role of the allostatic stress response network within the organism in adaptation, maladaptation, and the development of disease [5, 94, 95]. This paper will build upon concepts and findings from the CAS and allostasis-adaptation literatures integrating the research on homeopathic remedies and nanoparticle properties with physiological findings on the processes of adaptation and response amplification. The current model will facilitate development of specific, testable hypotheses for theory-driven homeopathic remedy research [39].

Literature informing model development

Principle (A). Homeopathic remedies are highly reactive source and/or remedy-modified silica (or polymer) nanoparticles, not bulk-form drugs [2, 3]; The active components of homeopathic remedies, other than plant mother tinctures, are nanoparticles of the source substance [2] and/or source substance adsorbed to the surface of or entrapped within silica or polymer vehicle nanoparticles [1, 3, 6265] in ethanol-water colloidal solution. At higher potencies, bottom-up nanosilica self-assembly and epitaxial templates from remedy source nano-forms encountered during earlier preparation at lower potencies could also acquire, retain, and convey remedy-specific information [3, 4, 78]. Other than in plant mother tincture concentrates [46], remedies are not purely bulk-form material drugs. Trituration of insoluble bulk form materials, which is mechanical grinding in lactose, would generate source material and lactose amorphous nanoparticles and nanocrystals [49, 79]. With or without source bulk-form material trituration, repeated succussions in ethanol-water solutions would generate not only remedy source nanoparticles [2, 3], but also silica (or synthetic polymer) nanoparticles and nanostructures from the walls of the glass (or synthetic polymer) containers in which the succussion occurs [3, 4, 56, 64].

Nanotechnology research suggests that variations in a number of different manufacturing parameters, e.g., glassware, solvent, pH, temperature, type of container, grinding methods, force and number of cycles of agitation of fluids, will affect the sizes, shapes, and properties of resultant nanoparticles [57, 58, 102]. For instance, smaller nanoparticles, e.g., 16 nm nanosilica, are generally more toxic to healthy cells than larger nanoparticles of the “same” material [103106]. However, compared with smaller NP sizes (e.g., 20 nm), larger size nanoparticles (e.g., 80 nm) of the “same” calcium phosphate source material induce apoptosis more effectively in osteosarcoma cancer cells [107]. Notably, the homeopathic remedy Calcarea Phosphoricum in low potencies has long been part of the Banerji treatment protocols for osteosarcoma and other cancers in India [108].

A recent empirical breakthrough in understanding the basic nature of homeopathic remedies demonstrated that even commercial metal remedies (source materials: gold, copper, tin, zinc, silver, and platinum) triturated, diluted and hand-succussed to 30C or 200C potencies (both above Avogadro’s number) retain nanoparticles of their source material [2]. Some have criticized the Chikramane et al. paper for using sample preparation methods that failed to detect size differences of nanoparticles at different potencies [109]. Nonetheless, the overlap of classical homeopathic manufacturing and mechanical top-down nanoparticle nanotechnology manufacturing methods and findings from other basic science laboratories converge with similar findings [3, 24, 64].

For instance, Upadhyay and Nayak [3] used electron microscopy to demonstrate nanoparticles and nanocrystals in three different homeopathically-prepared plant remedies at 1C through 15C potencies. The latter researchers also measured greater amounts of silicon in succussed than in unsuccussed remedies and water controls made in glass vials. Glass-vial succussed remedies exhibited greater silicon contents than plastic-vial succussed remedies [3], a finding consistent with previous studies [1, 4, 32, 74].

Das et al. [64] recently reported using four different homeopathic plant mother tinctures to biosynthesize silver nanoparticles, whose sizes and associated biological effects differed as a function of the specific plant used in their manufacturing. The data imply that interaction of metal nanoparticles with a bioactive material in solution can acquire unique properties as a result. Plant extracts can also induce formation of colloidal silica structures (cf. [71]). Such nanostructures could undergo the same types of remedy source adsorption and size modifications from biochemical interactions with specific plant or animal source materials, as now documented for biosynthesized silver NPs.

In an earlier paper, Rao et al. [24] suggested that the commercial homeopathic remedies they studied contained nanobubbles of oxygen, nitrogen, carbon dioxide, and possibly remedy source material, generated from the succussion component of homeopathic remedy preparation. They also proposed epitaxy (transfer of structural but not molecular information) as another mechanism by which specific remedy materials could transfer information to water structures in the ethanol-water solution [24]. Thus, both adsorbed remedy source nanoparticles and specific epitaxial information transferral to silica nanostructures [3] are viable hypotheses consistent with the large literature demonstrating individualized biological and physical chemistry specificity of different homeopathic remedies.

These data contribute to better understanding of reports from two other laboratories studying homeopathic remedies. For example, Elia et al. [26, 28] found that extreme changes in pH, e.g., strong alkaline pH, cause homeopathic remedy verums to release measurably excess heat and exhibit higher electrical conductivity compared with control solvents. They suggested that the heat release was energy from disruption of ordered structures in the remedy solutions that was not present in plain solvents.

Although Elia interpreted their findings in terms of changes in water structure [26, 28], their data are also consistent with a nanomaterial model. Since several studies have shown that succussion in glass vials releases measurable amounts of silica or its precursors [3, 4, 56], alkaline pH fosters formation of silica [110], and silica nanofluids exhibit increased electrical conductivity when temperature rises [111], the presence of nanoparticles could account for the increased heat release and electrical conductivity.

In addition, Elia et al. [26] reported that the amount of heat release and electrical conductivity increased when their remedy solutions were tested using extreme pH changes after storage in small volumes for extended periods of time at room temperature. Such findings are consistent with the strong thermodynamic tendency of smaller nanoparticles of remedy source and/or silica in liquid sols to aggregate spontaneously and/or self-assemble back into larger crystalline structures, e.g., via Ostwald ripening, unless specifically treated to prevent this phenomenon [112115]. In nanoscience, the material composition may not change, but the structural organization and properties can.

Furthermore, Rey [30] found that, under extreme in vitro external treatments with low temperatures followed by x-ray and gradual rewarming procedures, higher potency homeopathic remedies released measurably more light energy than did the control solutions. Rey also noted that two remedies differed from one another in thermo luminescence patterns, but retained the “fingerprint” properties of the original source substance, even without the detectable presence of the bulk-form source material in solution. Although Rey discussed his data in terms of the “memory of water” models, the latter findings are consistent with the persistent presence of identifiable remedy source nanoparticles in the verum test solutions [2] and/or residual specific remedy source material and information adsorbed and templated onto silica nanoparticles and silica nanocrystals [1, 3, 32, 64, 69].

On the one hand, silica NPs alone could not explain Rey’s ability to use thermo luminescence for distinguishing different homeopathic source materials from one another at lower or higher potencies. Other laboratories have also been able to distinguish one specific higher potency remedy from one another and from succussed solvent controls using Raman and UV–vis spectroscopic methods [24, 116], as well as less well-known technologies [117, 118]. In contrast, NMR spectroscopy and infrared spectroscopy on different remedies have yielded both positive [32, 119] and negative results [86] distinguishing specific remedy solutions from controls. On the other hand, persistent remedy source nanoparticles and remedy-modified silica nanostructures could provide an alternative explanation of Rey’s findings of source-specific information. It is a step forward to recognize that the remedy source information would be present starting in very low potencies not only as bulk-form material, but also as source nanomaterial, while serial dilutions and succussions proceed toward higher potencies. Even if the bulk-form materials might be progressively diluted out of higher potencies, the evidence indicates that the remedy nano-forms and/or their information persist [2, 3, 9].

Recent homeopathic research contributes to insights about minimally necessary factors to make biologically active remedies. For example, trituration of Arsenicum Album, followed by dilution without succussion up to a modified 200C, could still generate biologically active medicine [120]. However, dilution without prior trituration or subsequent succussions of cytokines, produced much less biological activity than succussed forms of the “same” agent [121]. These findings suggest that either trituration or succussion is minimally essential for an active homeopathic remedy; each procedure would mechanically generate nanoparticles [51].

Optimally, however, as Hahnemann reported in combining trituration and succussion to prepare homeopathic remedies [40], nanotechnologists have also found that combining mechanical wet grinding with sonication (agitation in liquid solvent) is more effective than either method alone for forming, de-aggregating, and dispersing nanomaterials [54]. Increased dynamic solute aggregation can occur in aqueous solutions prepared with more versus less dilution, that is, lower initial solute concentrations [122]. Thus, the cumulative shear forces and greater de-aggregation from the additional succussions done while making increasingly higher potencies might translate into smaller sized remedy nanostructures.

Variability in nanoparticle sizes, shapes, and associated properties [103, 104] would contribute to the known variability in clinical responses to a specific homeopathic remedy dose. It also explains some of the reproducibility challenges that have been identified in the literature [123, 124]. These issues do not negate the validity of homeopathy; rather, they suggest theory-driven directions for systematic research on the variability in remedy nanoparticles, the potential NP contributions to variability in experimental reproducibility in homeopathy, and new ways to evaluate and control specific variables involved in manufacturing methods [1, 2] and safety assessments [45, 125].

Given the growing body of empirical evidence about the nanoparticle nature and biological activities of homeopathic remedies [24, 710, 123], it is time to question the conventional assumption that homeopathic remedies are “simply” dilutions of ordinary bulk-form drugs containing “nothing” but unmodified alcohol and water. The actual evidence suggests that homeopathic remedies are low doses of different sizes and shapes of nanoparticles and nanocrystals of their specific remedy source as well as silica nanostructures with remedy source material adsorbed to their surfaces [2, 3]. In this context, even higher remedy potencies retain source-specific structural and electromagnetic “memory” of information within (i) the nanoremedy NPs and (ii) nanosilica structures [64, 83] that initially would self-assemble in “bottom-up” aggregates [67, 76, 77, 126, 127], around the remedy source materials as structural (epitaxial) templates in solution [122]. Thus, as an alternative to the “memory of water” debate surrounding homeopathy, an empirically-grounded hypothesis would be the “memory of source and source-modified silica nanostructures.”

The organism treats many types of exogenous nanoparticles, including nanosilica [81, 82, 128, 129], as threats to its survival. Local cellular interactions with NPs can lead to systemic signaling [130]. NPs from a salient homeopathic remedy in potency could act mainly as a novel, low level threat or exogenous stressor, signaling danger that sets adaptive responses into motion within the physiological and biochemical dynamics of the whole organism [94, 128]. Homeopathic remedies would thus act more as low level triggers for systemic stress responses than as pharmacological drugs on specific local tissue receptors [8, 37].

Principle (B). Homeopathic remedy nanoparticles, administered intermittently over time [40], act as biological stressors that signal [9] a low intensity novel “threat” to the allostatic stress response network.

 Allostatic stress response network

The immediate interface between the environment and the organism is the allostatic nonlinear stress response network (Figure 2). In the context of physiology, a stressor is any type of environmental or exogenous stimulus or signal that perturbs the system’s homeostasis and sets compensatory adaptive changes into motion. The range of stressors can include biological, infectious, chemical, physical, nutritional, electromagnetic, and/or psychosocial types, i.e., changes that constitute a perceived threat to the survival of the organism. A lower intensity stressor that stimulates adaptive plasticity and regulates the system bidirectionally to restore homeostasis is acting on endogenous processes of adaptation. Well-chosen homeopathic remedy nanoparticles (simillimum) act as deep-acting plasticity-modifying signals in chronic diseases. In nanoparticle form, remedies effect these changes by modulating genetic pathways as well as the nonlinear dynamical function of biological defenses in the organism as a complex system [9, 131133], shifting from a maladapted attractor pattern to a healthier attractor pattern [10, 20, 21].

Figure 2

Nonlinear allostatic stress response network: interface with environmental stressors, including homeopathic remedy nanoparticles. This schematic shows some of the physiological components involved in the organis’s response to stress and the complex, nonlinear interrelationships as a network within which they regulate one another. Pathways in the central nervous system, including amygdala, prefrontal cortex, and hippocampus, involved in stress responsivity and reward, learning and memory, somatosensory function, emotional function, and motor activity regulate and interact with all of the above components. Disease is an emergent outcome when the cumulative stress load overwhelms the adaptive capacity of the system and the interactions become persistently dysregulated. Targeted, timed disruption of the dysfunctional dynamics of disease affords the system an opportunity to recover normal regulatory relationships and interactions across the biological network [23]. The present model postulates that the correct homeopathic remedy provides such a disruption to initiate adaptive changes. Used with permission from [5].

In a complex adaptive system, the allostatic network initiates plastic and metaplastic adaptations that evolve over time, preparing the organism to maintain and/or restore homeostasis more effectively in the future if and when it next encounters a similar stressor/signal. These biological signals must be spaced over time to avoid overwhelming the organism’s compensatory capacity. McEwen [134] emphasized the primary role of the brain as one of the controlling hubs in the human being as a complex organism, intercommunicating with bodily cells and regulating the rest of the stress response network.

In an intact complex organism, cells would send signals to the brain via the allostatic network [135, 136], e.g., cytokine activation patterns [137]. Perception and processing of environmental threats from exogenous stressors occurs in prefrontal cortex, hippocampus, and amygdala [6, 138]. In this context, the salient remedy signals those brain regions with a perceived low level threat to survival of the organism. Consistent with this conceptualization, a previous homeopathic research study demonstrated unique prefrontal EEG cordance reactions to sniffing individualized remedies in human subjects [139]. However, remedies can also initiate responses at lower local levels of organizational scale. Thus, isolated cells as biological systems can detect and respond to environmental stressors [93, 140142]. However, in vivo, cells and organism maintain a bidirectional, interactive influence on one another [143]. Local cellular changes send biological signals to the larger system in which they are embedded, and vice versa [94, 130].

Changes in the function of such a major network within an organism by necessity induce changes in other physiological networks with which it interacts. In turn, changes in bodily networks interact bidirectionally with the emergent global properties of the organism as a whole [101, 143]. Thus, when remedy nanoparticles signal a novel environmental threat to the immune system [10], brain and/or other components of the stress response network, their effects are indirect and magnified over time by the organism[21, 23, 94].

The nonlinear allostatic stress response network includes not only the immune system and brain, but also other interactive, mutually regulatory mediators of adaptation: e.g., cortisol, parasympathetic and sympathetic branches of the autonomic nervous system, metabolic hormones, and biological mediators such as inflammatory and anti-inflammatory cytokines [5]. In the allostatic model of disease, the cumulative overwhelming effects of previous stressors (biological, infectious, physical, electromagnetic, chemical, nutritional and/or psychosocial) initiate persistent dysregulations in the biology of the organism’s stress response network. This allostatic overload causes adverse changes in functional set points, from which the body is unable to recover on its own. The process creates chronic physiological imbalances and permissive conditions for cumulative damage that manifest with symptoms of disease [5, 95, 144]. These chronic changes in functional set points would correspond in the terminology of complex adaptive systems to becoming “stuck” in a more rigid and less adaptive dynamical attractor pattern [10, 20, 23, 145].

This aspect of the model has support in the basic science research literature on homeopathic remedies. Remedies can mobilize various elements of the allostatic stress response network in vitro and in vivo. Previous empirical studies have shown that different homeopathic remedies modulate components of the allostatic stress response network. These findings include remedy-induced changes in heat shock proteins [7, 17, 146], cytokines [147149], immune [150153], metabolic [12, 131], and nervous system [154162] function, as well as gene expression patterns [9, 163, 164]. Nanoparticles per se can and do mobilize components of the allostatic network [165167]. Because of the interconnected network nature of the allostatic network, however, in vivo studies, which allow the brain and body to carry on their usual bidirectional homeostatic interactions with one another, are most likely to capture the hypothesized role of the allostatic network in adaptation [96] after remedy administration.

The specific pattern of the biological responses depends in part upon which components of the stress response network are initially involved [168, 169]. For instance, an infectious agent or environmental nanoparticles would likely interact first with elements of the immune system [165, 167], but then the cytokines released as part of the immune and inflammatory response in the allostatic network would modulate brain function, leading to changes in emotional state, mood and energy levels [136, 170]. In the “other” direction from above downward in the stress response network, chronic disturbances in brain function such as sleep deprivation can mobilize sympathetic nervous system tone, inflammatory cytokine release, and glucocorticoid activity [171]. If any function begins to go up or down, other components of the network will mobilize to regulate and modulate the extent of the change.

Possible mechanisms from stress signaling capabilities of remedy NPs

The proposed endogenous process begins with the homeopathic remedy nanoparticles serving as novel stressors that signal a salient, organism-wide threat. Skeptics might argue that even with the nanoparticle finding, the quantities are “too low” to make a difference as direct conventional pharmacological agents acting at local receptors. However, “low” doses of nanoparticles, which are inherently highly bioactive and catalytic, can be very low and still elicit meaningful biological responses as biological signals for adaptive changes [79, 16, 131, 172, 173]. Chikramane et al. [2] found measurable quantities of metal remedy source in the nanoparticles they observed from commercially-prepared, hand-succussed remedies were in the range of 1 to 4000 picograms/ml (approximately 0.05 to 200 pg in a one drop liquid dose). For perspective, one picogram of genetic material from a virus (nanosize 10–150 nm), depending on the virus, could contain approximately 1,000,000 or more virus particle equivalents [174]. Physiological levels of various hormones are in the pg/ml range.

How would remedy nanoparticles convey their source-specific information to the allostatic network of the organism? Once generated, nanoparticles can signal specific information about their entry into the organism via their altered size- and shape-dependent chemical, optical, electromagnetic, magnetic, thermal, and/or quantum properties [33, 48, 6062, 175]. Data from the nanoparticle research literature suggest multiple non-exclusive options: (i) Remedy nano-forms inherently lower the necessary dose levels [90] because of their enhanced bioavailability, intracellular access [90], and biological signaling effects [130], e.g., for plant and mineral source materials; (ii) Silica NPs and crystals act as cellular stressors [128] and adjuvants, i.e., non-specific biological amplifiers [81, 82], to stimulate immunological and/or inflammatory reactivity on their own [130] or to source-specific NPs or antigen [176]. Remedies modulate specific genomic expression patterns as well [9, 163, 164].

In addition, quantum phenomena emerge in extremely small sized NPs with more atom-like characteristics (e.g., <50 nm) [48]. Chikramane et al. [2] reported homeopathic metal remedy NP sizes in the range of 5–10 nm, with the majority of crystallites below 15 nm in size. Thus, some remedy source NPs and/or silica nanostructures templated onto source materials during initial manufacturing steps might also convey remedy-specific information into higher potencies via quantum macro entanglement effects [61] in living cells [177]. Rather than treat the evidence for quantum phenomena in homeopathic remedy testing as a curious anomaly [34], the present model allows the possibility that the quantum mechanical properties of very small nanoparticles [61, 178] could further explain some data on homeopathic remedies and variability of experimental reproducibility with placebo-controlled study designs [34, 44].

By whatever mechanism(s), the most immediate locus of action of the correct homeopathic remedy would be the allostatic stress response network. The remedy nanoparticles would serve as a significant and salient exogenous danger signal that stresses and thus perturbs the organism’s physiological and biochemical dynamics (cf. [179]). The state of the organism at the time of dose administration is an essential factor in the magnitude and direction of the effects. If the dynamics are currently dysfunctional or diseased, the low dose remedy-elicited perturbation “unsticks” the system [10, 20, 145]. The disruption provides the system an opportunity to adapt [93] – i.e., to readjust its processes [23], engage its plasticity [16, 23, 180182], reverse direction, and restore healthier balance across its global emergent function and local network components [23, 93, 181, 183]. In the pharmacology and physiology literatures, this beneficial adaptive process is termed hormesis.

Principle (C). The mediating processes for remedy effects are physiological, not pharmacological [184]. They include adaptive plasticity and metaplasticity [181, 185] of the organism to amplify [169] and modulate the direction of its responses to a salient homeopathic remedy with the passage of time [23], as a function of the organism’s past history [186, 187].

 Hormetic changes

Mattson [188] defines hormesis as follows: “Hormesis is a term used by toxicologists to refer to a biphasic dose response to an environmental agent characterized by a low dose stimulation or beneficial effect and a high dose inhibitory or toxic effect. In biology and medicine, hormesis is defined as an adaptive response of cells and organisms to a moderate (usually intermittent) stress.” Hormetic effects are nonlinear and depend on specific adaptive changes in the organism, not on specific pharmacological effects of the substance[184]. Nanoparticles can cause hormesis [16].

Of relevance to the low doses used in homeopathic treatment, the small size and heightened reactivity of nanoparticles [60] that increase bioactivity and bioavailability of drugs, antioxidants, and herbs [62, 63, 68] would downshift the hormetic dose–response range even lower [39]. As a result, the small quantity of remedy needed to produce an effect – in nanoparticle form – would fall into the hormetic range [12], potentially far below the already low doses at which this phenomenon usually occurs for bulk-form materials [189, 190].

The evolutionary advantage of low dose stimulation rather than inhibition of function is postulated to be the survival advantage conferred on the organism [191]. The compensatory changes in response to the low dose exposure pre-adapt the organism in a manner that will make it more resistant to a repeat danger from the same stressor, or a cross-adapted stressor [8], at an even higher, more toxic or lethal potential dose level [192]. At the same time, living systems self-regulate within a relatively narrow range of function to maintain homeostasis. For example, if certain brain neurons of an organism have a lowered threshold for firing after responding to a given stimulus, then the next stimulus would raise the threshold, and vice versa [181]. As a result, low intensity stimuli can activate, and high intensity stimuli dampen, responses [181].


Cross-adaptation is a well-documented physiological and biochemical phenomenon [168, 169, 182, 193, 194]. In cross-adaptation, unrelated types of stressors, e.g., hypoxia versus cold temperatures, can affect the same intermediaries in the biological allostatic network [7, 8, 187, 193]. That is, although two types of environmental stressors can be quite different in nature, the organism mobilizes the same set of adaptive changes and subsequently copes better physiologically with both stressors [168, 182, 193, 194]. Living systems have a broad, but nonetheless circumscribed, repertoire of possible behaviors in response to environmental challenges. Evolutionary efficiency may have left the organism with the ability to prepare itself against a range of future stressors by initially adapting to one type of stressor [191].

The direction of changes in cross-adaptation can be bidirectional. That is, a given environmental stressor can cause adaptive changes in the organism that make it more or less fit to resist the adverse effects of a different type of stressor [181, 182, 195]. As in hormesis, low intensity stressors often produce adaptive changes in the opposite direction to high intensity stressors of the same or different type [16, 98]. The direction and nature of the response depends on the initial conditions of the organism, past history of the organism, the pattern of adaptive responses that the specific stressor can evoke, and the capacity for adaptation that the organism can achieve [169]. Cross-adapted responses involve the same compensatory mechanisms in the body that the individual’s cumulative past specific stress load has already primed and modified.

When the salient homeopathic remedy serves as a low-level novel but cross-adapted stressor, salutary effects would evolve over time because of pre-existing adaptations to disease-related stressors that the organism had already developed. In the current model, the remedy nanoparticles would mobilize a biological cross-adaptation response [168, 169, 182, 194] to the net effects of the original stressors that previously led to the disease state. The direction of changes to the remedy in the organism, however, would be opposite to those of the higher intensity stressors that originally caused disease. That is, well-matched homeopathic remedy nanoparticles mobilize cross-adaptation within the same allostatic network components that the individual’s disease had previously affected.

Thus, a homeopathic clinical profile would need to match global and local symptom patterns and modalities of expression for the correct remedy (simillimum). The simillimum for an individual patient who is made worse by the approach of a storm or hot temperatures (e.g., particular physical generalities or modalities in the homeopathic clinical literature -[196]), must be a novel stressor with the ability, at higher doses, to evoke a similar, specific set of physiological adaptations to dropping barometric pressures or hot environmental temperatures [182, 194, 195]. A remedy whose source material bulk form has no effect either way on the specific adaptations [195] needed to restore homeostasis during the approach of a storm or in hot temperatures would be less likely salient – i.e., therefore less clinically active -- for such an individual.

The nature of the responses that the correct remedy can elicit in the organism is similar to the nature of the dysfunctional responses that the previous stressors initiated as allostatic maladaptations [95]. As the remedy nanoparticles were not the original causative agent for disease, researchers would consider it to be a “heterotypic” hormetic stressor for the organism [8, 169]. The prior experience with stressors involved other types of higher intensity stressors that can cross-adapt with the remedy effects on the physiology and biochemistry of the stress response network [187, 197]. In short, a well-chosen homeopathic remedy can cause the same adaptational symptom pattern as the disease-causing stressors at high doses, but it acts in discrete low doses as a novel, i.e., heterotypic or heterologous hormetic stressor [10, 198].

Metaplasticity and time-dependent sensitization

Metaplasticity, i.e., the plasticity of plasticity, involves activity-dependent cellular and molecular priming mechanisms that initiate long-lasting changes in the expression of subsequent neuronal plasticity [181]. This priming process occurs in neural networks involved in regulating learning and memory, including addictions [181], as well as emotion [199], somatosensory perception [200], and movement [201]. These pathways include prefrontal cortex, hippocampus and amygdala [199, 202]. Changes in neuronal excitatory amino acid receptors such as N-methyl-D-aspartate (NMDA) receptors are key participants in metaplastic mechanisms as well as in neuronal damage after injuries to these brain regions. Glutamate is an exemplar excitatory amino acid that affects NMDA receptors. Notably, Jonas’s research team previously demonstrated that low doses of homeopathically-prepared glutamate can attenuate or reverse direction of adverse effects from high dose glutamate exposure in neuronal cells [160, 203].

One stimulus/stressor initiates the metaplasticity; the next stimulus/stressor (the same or a cross-adapted stimulus) elicits plastic responses modified by the history that the organism had with the original stimulus. Pushing the system toward its limits leads to a propensity to reverse direction in encounters with subsequent stimuli [186]. One example is the Bienenstock-Cooper-Munro rule for experience-dependent plasticity, in which low level cortical activity increases, whereas high level cortical activity decreases, synaptic strength of active neuronal connections [181, 204]. Metaplastic changes can occur at stimulus levels below those needed to elicit observable plastic changes and persist long after exposure to the original stressor ends. Low level and high level stressors can initiate metaplastic changes in opposite directions [98, 181].

Time-dependent sensitization (TDS) is a form of metaplastic adaptation that generates progressive endogenous response amplification with the passage of time between repeated, intermittent stimuli or stressors. Homeopathic remedy nanoparticles as stressors for the cells and overall organism would be capable of initiating and/or eliciting TDS. As in any type of neuronal plasticity phenomenon, the initiation and elicitation steps of TDS are activity-dependent. After the initiating exposure, the system prepares itself with compensatory changes that amplify over time -- “a sensitized defense response, enabling it to react faster and/or more strongly, should it ever reencounter the same or a similar stimulus” [187]. The novelty of the pulsed or intermittent quality of the dosing regimen for the organism is essential to set endogenous amplification responses into motion; continuous or ad lib exposures do not mobilize sensitized states [187, 205]. In TDS, the initiating and eliciting stressors or drugs must also be individually salient for the organism [97, 187, 206].

For hormesis [16, 38], cross-adaptation, and/or TDS [98, 187] to occur in response to a homeopathic remedy dose, the remedy must be perceived or experienced as a salient but low level foreign threat or novel biological stressor, i.e., a potential disruption of homeostasis for the organism as a whole. Changes in glucocorticoid hormones and corticoid receptors, major components of the allostatic stress response network, are a necessary but not sufficient early condition for the initiation of TDS [207209]. For a remedy to be clinically effective, its salience is not to the end organ local mechanisms of symptoms (pharmacological), but rather to the intermediary adaptations in the allostatic stress response network components of the organism (physiological). The growth in magnitude of the response derives from TDS-based amplifications in the physiological adaptations of the organism, not directly from the size of the initiating stimulus or stressor. Figure 3 summarizes the role of the organism in experiencing nanoparticles as exogenous stressors and/or pharmacological drugs (or toxicants).

Figure 3

Dual possible pathways (stressor and/or pharmacological drug) for exogenous agents, including nanoparticles, for effects on living systems. Exogenous nanoparticles (from pollution, nanomedicine drugs, or homeopathic remedies) might serve as stressors to trigger adaptation and/or specific pharmacological agents (drugs, toxins) to activate specific receptors on local tissues, at higher dose levels. However, although the dose would sometimes be insufficient to act as a specific conventional pharmacological drug, the low levels of nanoparticles found in a homeopathic remedy could act as stressors for the organism (homeostatic disruptors). Therefore, homeopathic remedies would engage mainly the stress response network pathway, whereas conventional bulk form drugs affect both pathways (stressor and drug).


Like cross-adaptation, cross-sensitization of amplified responses also occurs. Chemically-unrelated agents, e.g., stress and amphetamine or cocaine [209], sucrose and stimulant drugs or alcohol [210, 211], formaldehyde and cocaine [212], stress and morphine [213], stress and diazepam [214], can all cross-sensitize with one another. One agent initiates and a different agent elicits sensitized responses. Antelman interpreted these ubiquitous cross-sensitization findings to indicate that the shared feature of the drugs, food, or environmental stimuli was their quality as novel and threatening stressors, i.e., individually salient “danger signals” for the organism, rather than their pharmacologically specific actions [187]. Given the interdisciplinary nature of the present model and discipline-related variations in terminology, the neuroscience concept of cross-sensitization also overlaps that of “heterologous priming” a term from a more immunologically-oriented perspective [10], or “heterologous post conditioning hormesis,” a term from pharmacology-toxicology and physiology [7, 189].

Repeated intermittent episodes of exposures to the same or a cross-sensitized stressor can elicit progressively larger responses with the passage of time in TDS [169, 187, 206]. However, at metaplastically-primed physiological limits, sensitized responses will change direction (oscillate) with each successive dose [97, 186, 187], thereby potentially promoting recovery from disease if chosen for salience and properly timed[11]. As previously noted, in physiology [169, 181, 215] and behavioral sensitization studies of non-homeopathic stressors and drugs [97, 98, 216218], the low versus high dose and the state of the organism interact to produce polar opposites in the direction of the response to the “same” stressor or stimulus.

Together with cross-adaptation, these related phenomena of TDS cross-sensitization and metaplastic oscillation would help explain the clinically-reported ability of a homeopathic remedy to reverse chronic individualized maladaptive patterns in the organism. That is, the remedy NPs are not only cross-adapted, but also cross-sensitized to the overall disease-related dysfunctional changes that are previously established in the organism at the moment of remedy administration. The disease is a sensitized emergent set of previously-amplified dynamical behaviors (allostatic maladaptations) that the body accumulated in response to past higher intensity stressors of all types. These cumulative allostatic disturbances manifest as dysfunctional biological dynamical patterns, induced while the organism was trying unsuccessfully to cope with overwhelming cumulative stress effects of adverse childhood experiences, past life traumas, infections, environmental chemical pollutants, physical stressors, psychosocial stressors, poor nutrition, and/or various other epigenetic factors [5, 95, 134].

In the present model, a low dose of the correct remedy nanoparticles would push the overloaded allostatic network to its metaplastically-primed physiological limits, which might induce a transient worsening of symptoms, i.e., homeopathic aggravation, before a reversal of direction of the sensitized response occurs [219]. A true aggravation reportedly includes a global sense of increased well-being, suggesting central nervous system involvement at the onset of the remedy response, even though local physical symptoms may temporarily flare, sometimes in association with an acute onset infection [220].

Alternatively, the correct remedy NPs could arrive in the organism at a point when the system dynamics are already disease-primed to a critical dynamic point or maximum physiological limit [8, 23]. In the latter case, the reversal in direction from disease toward healing ensues without transient symptom aggravation. Conversely, if the remedy is given to a healthy organism, its metaplastic effects evolve in the direction of enhancing, not reversing, disease-related adaptations [11]. This history- and state-dependent type of variability in response direction and amplitude is well-documented in the physiological literature on adaptation, cross-adaptation, metaplasticity, and cross-sensitization in complex adaptive systems [181, 182, 186, 187, 195, 216].

Homeopathic clinical research provides support for the involvement of TDS. Convergent research indicates that sensitization of the central nervous system pathways related to pain is a key mechanism in fibromyalgia (FM) [221]. In persons with FM [222], we found that repeated intermittent doses of individualized homeopathic remedies initiate progressively sensitized (amplified) responses of electroencephalographic alpha activity [154], with specific unique changes over time in prefrontal electrode sites for the responders with both global health and local pain improvements [223]. In persons with a mild form of multiple chemical sensitivity, an FM-related condition also tied mechanistically to TDS, repeated intermittent sniffs of an individually-salient homeopathic remedy can induce short-term EEG alpha effects that are nonlinear and even oscillatory in directionality [14].

As types of metaplasticity, both hormesis and TDS mobilize adaptive or compensatory changes in an organism [23] in response to the appraised threat from novel or foreign stressors, biological agents, chemicals, physical stressors, and/or drugs, including nanoparticles [16]. These organism-based, nonlinear adaptive changes evolve separately from any direct specific pharmacological actions on receptors, do not require the continued presence of the initiating agent, and are thus pharmacologically “nonspecific” [7, 8, 187]. Rather, the organism-based response pattern is specific to the past history and initial state of the organism, the passage of time, and the timing of repeat doses [5, 16, 23, 187, 191].

 Pulsed dosing regimens in modulating cells and organisms as nonlinear dynamical systems

As in TDS, classical homeopathic practice theory suggests the value of using discrete pulses of a remedy (i.e., “nanoparticle”) dosed at very low quantities in a timed manner as biological signals to initiate healing and stimulate the self-reorganization of the organism [224]. However, current mainstream studies are still focused on using nanomedicines in relatively higher amounts, as if they were conventional drugs to force a direct local action, requiring continuous blood levels, rather than intermittent pulsed dosing. Still, nanoparticles reduce the total amount of a drug or herb needed to produce a given effect [63, 225].

The distinction for homeopathy is that the low level nanoparticle exposures occur at discrete points in time, pulsed doses in the salutary low dose hormetic range. The therapeutic intervention involves small quantities of nanoparticles, (a) selected for salience to the individual’s unique emergent maladaptive pattern, and (b) given in discrete pulses at widely spaced intervals of time as organism-specific stressors that evoke an endogenous cascade of adaptive changes [224]. Without the remedy NPs as a discrete low intensity eliciting stimulus, the organism’s metaplastic priming would not express itself.

Research on dynamical diseases in complex adaptive systems has shown that pulsed, properly-timed stimuli can interrupt the dynamics of a pathophysiological process such as a seizure [226] or a cardiac arrhythmia [227] and cause the affected system to revert to normal function [228]. Once an interconnected part of a complex system or network changes its dynamics, the alterations will then cause additional, albeit indirect, changes distant in space and time from the site of the original stimulus [20, 23]. Complex networks undergo recurring mutual interaction patterns (motifs) between global and local organization and function [93, 94, 142, 143].

The pulsed intervention strategy allows the bodily networks to respond to the remedy nanoparticle stimulus, and gives the system time to incorporate changes that further inform changes and adaptive responses [21, 22]. Similarly, TDS also requires intermittent stimulus dosing for its initiation and evolution [229], thereby allowing the system time to complete the endogenous amplified adaptive changes following each dose [230232], before giving the next dose. In sensitization, a drug or biological substance acts as an environmental or exogenous stressor to disturb homeostasis and initiate adaptive responses that amplify with the passage of time, without the continued presence of the initiating agent [187, 233]. The capacity for nonlinear amplification of effects from an initially small stimulus in a complex living system such as a human being is well-established [23]. Thus, the rationale for the pulsed dosing regimen relates to the role of the correct remedy in stimulating endogenous adaptive changes to an exogenous stressor, not in its use as a pharmacological agent.

Principle (D). Successful homeopathic treatment strengthens systemic resilience.

Resilience in a system permits it to bounce back to normal function on its own after the impact of a given environmental stressor or challenge [23]. The successfully treated individual can resist and rebound from subsequent challenges from higher intensity homeostatic disruptors of the organism as a complex network, at global and local levels of organizational scale [234].

In complex adaptive systems terms, a resilient system is able to function well within the fitness landscape or environment in which it is embedded [235]. Faced with change, a healthy organism is flexible and able to make further adaptive changes to bring itself back to homeostasis and normal functionality in the context of the modified environment [23, 236]. Of course, overwhelming change or a hostile environment might again cause allostatic overload, adverse shifts in functional setpoints, and recurrent disease, necessitating further homeopathic treatment.

Because of the interactions and interdependence of subnetworks within a person’s larger complex network organization [92, 101], positive adaptive changes in the function of the stress response network would, by necessity, foster an evolving cascade of additional adaptations and persistent positive changes across the rest of the organism, i.e., system-wide healing into greater resilience [21, 22, 145]. As we have previously proposed [21, 22, 237], the self-organized, interconnected network nature of the person [101] would underlie the clinically-reported pattern of homeopathic healing over time, i.e., from above downward, from more important to less important organs, and in reverse order in time of symptom appearance [238]. The pattern of clinical response usually begins in the brain because of its central role in interpreting and coordinating physiological responses of the body to perceived environmental threats and stressors. The global sense of well-being and symptom improvements at end organs would occur, but as an indirect and possibly temporally delayed, outcome of restoring allostatic network function to normal [136].


In summary, the basic tenets of the model are [39]: Homeopathic remedies are remedy source nanoparticles and/or remedy-modified silica NPs that act as environmental stressors to mobilize hormesis and time-dependent sensitization via non-pharmacological effects on specific biological adaptive mechanisms. Both top-down mechanical attrition (trituration milling in lactose; succussion in glass with ethanol-water diluent) and plant-tincture biosynthesis methods generate the initial nanostructures. The nanoparticle nature of remedies distinguishes them from conventional bulk form drugs in structure, morphology, and functional properties. Furthermore, remedy source nanoparticles, especially in interaction with nanosilica, have the capacity to initiate bottom-up self-assembly of biomimetic nanostructures using crystalline or biological, e.g., DNA, proteins, collagen, templates [71, 76, 239]. Like a virus, albeit non-infectious, the homeopathic remedy thus becomes a salient low-level danger signal or threat to the survival of the organism.

The outcomes depend upon the ability of the organism to appraise the original high level stressors that caused disease and the subsequent low level remedy nanoparticles as novel and salient foreign stressors. Factors identified as biological threats will signal the need for time-dependent, sensitized compensatory adaptations (hormesis) in components of the allostatic stress response network.

The cumulative impact of allostatic overload from multiple different stressors led in the past to a pattern of specific dysfunctional adaptations in the stress response network underlying the emergence of disease [195, 240]. The cross-adapted/cross-sensitized homeopathic remedy nanoparticles take advantage of the priming effect of the prior high level stressors that originally caused the disease [10]. The remedy nanoparticles, as a low level stressor, then elicit reversal of direction in the pre-established, disease-related maladaptive patterns. The net outcome is improved resilience to stress, with restoration of normal homeostatic function, resolution of disease, and an emergent sense of global well-being.

Again, “stress” refers to biological, infectious, chemical, physical, electromagnetic, nutritional and/or psychological types of environmental stimuli that the organism recognizes as a novel threat to its survival, now or in the future. The high or low intensity of the stressor determines the direction of the adaptations it initiates [98, 187, 216], but it is the encroachment of the stressor on the organism that mobilizes plastic and metaplastic changes. In short, perceived or experienced novel threat is more important than dose level to trigger adaptive responses. Dose comes into play to modulate the direction of the responses via priming from past cellular activity history, e.g., metaplasticity, and current plasticity in the body’s stress response pathways [181].

Within the organism as a complex adaptive system or network, causality for these events is indirect rather than direct, distant in time and space to the original administration of the homeopathic dose as a small but salient stimulus or stressor [241]. The organism carries forward the work of healing as a nonlinear, amplified dynamical adaptive response [2123, 145]. It is because of the nature of classical homeopathic prescribing, i.e., selection of a single remedy administered intermittently, at widely-spaced intervals of time in pulsed acute dosing regimens that the treatment system is safe and beneficial.

Table 1 summarizes the parallels between key homeopathic clinical concepts and concepts found in the basic science literature on nanoparticles, hormesis, time-dependent sensitization, allostatic adaptation, and complex adaptive systems.

Table 1 Parallels between homeopathic and modern scientific research literatures


The proposed model suggests that homeopathy is not only scientifically “plausible,” but also grounded in an extensive empirical research literature. Homeopathic remedies come into existence and exert their biological effects mainly as nanostructures. Physiology, not pharmacology, is the most relevant discipline for studying remedy nanoparticle actions (cf., [184, 187]). This paper insists on logic and rationality, as well as open-minded thoughtfulness, in evaluating the scientific implications of a large body of interdisciplinary evidence that health researchers might not otherwise assemble to understand homeopathic remedies. As empirical data arise, it is quite likely that new evidence will lead to modifications of the present theory; such is the nature of scientific inquiry. Nevertheless, this model provides a rational starting place for a comprehensive research program on homeopathic remedy actions. The resultant findings on what homeopathic remedies are (highly reactive nanoparticles) and how they interact with complex living systems (as pulsed, low level doses of a salient and novel environmental stressor) could significantly advance the field as a valuable form of nanomedicine.



Complementary and alternative medicine


Complex adaptive system








Time-dependent sensitization.


  1. 1.

    Bhattacharyya SS, Mandal SK, Biswas R, Paul S, Pathak S, Boujedaini N, Belon P, Khuda-Bukhsh AR: In vitro studies demonstrate anticancer activity of an alkaloid of the plant Gelsemium sempervirens. Exp Biol Med (Maywood). 2008, 233 (12): 1591-1601.

  2. 2.

    Chikramane PS, Suresh AK, Bellare JR, Kane SG: Extreme homeopathic dilutions retain starting materials: A nanoparticulate perspective. Homeopathy. 2010, 99 (4): 231-242.

  3. 3.

    Upadhyay RP, Nayak C: Homeopathy emerging as nanomedicine. International Journal of High Dilution Research. 2011, 10 (37): 299-310.

  4. 4.

    Ives JA, Moffett JR, Arun P, Lam D, Todorov TI, Brothers AB, Anick DJ, Centeno J, Namboodiri MA, Jonas WB: Enzyme stabilization by glass-derived silicates in glass-exposed aqueous solutions. Homeopathy. 2010, 99 (1): 15-24.

  5. 5.

    Karatsoreos IN, McEwen BS: Psychobiological allostasis: resistance, resilience and vulnerability. Trends Cogn Sci. 2011, 15 (12): 576-584.

  6. 6.

    McEwen BS: Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol. 2008, 583 (2–3): 174-185.

  7. 7.

    Van Wijk R, Wiegant FA: Postconditioning hormesis and the homeopathic Similia principle: molecular aspects. Hum Exp Toxicol. 2010, 29 (7): 561-565.

  8. 8.

    Van Wijk R, Wiegant FA: Postconditioning hormesis and the similia principle. Front Biosci (Elite Ed). 2011, 3: 1128-1138.

  9. 9.

    Khuda-Bukhsh AR, Bhattacharyya SS, Paul S, Dutta S, Boujedaini N, Belon P: Modulation of signal proteins: a plausible mechanism to explain how a potentized drug secale cor 30C diluted beyond avogadro's limit combats skin papilloma in mice. Evid Based Complement Alternat Med. 2011, 2011: 286320-

  10. 10.

    Bellavite P, Ortolani R, Pontarollo F, Pitari G, Conforti A: Immunology and Homeopathy. 5. The Rationale of the 'Simile'. Evid Based Complement Alternat Med. 2007, 4 (2): 149-163.

  11. 11.

    Bertani S, Lussignoli S, Andrioli G, Bellavite P, Conforti A: Dual effects of a homeopathic mineral complex on carrageenan-induced oedema in rats. Br Homeopath J. 1999, 88 (3): 101-105.

  12. 12.

    Malarczyk E, Pazdzioch-Czochra M, Graz M, Kochmanska-Rdest J, Jarosz-Wilkolazka A: Nonlinear changes in the activity of the oxygen-dependent demethylase system in Rhodococcus erythropolis cells in the presence of low and very low doses of formaldehyde. Nonlinear Biomed Phys. 2011, 5 (1): 9-

  13. 13.

    Hyland ME, Lewith GT: Oscillatory effects in a homeopathic clinical trial: an explanation using complexity theory, and implications for clinical practice. Homeopathy. 2002, 91 (3): 145-149.

  14. 14.

    Bell IR, Brooks AJ, Howerter A, Jackson N, Schwartz GE: Acute electroencephalographic effects from repeated olfactory administration of homeopathic remedies in individuals with self-reported chemical sensitivity. Altern Ther Health Med. 2012, in press.

  15. 15.

    Bell IR, Howerter A, Jackson N, Aickin M, Bootzin RR: Nonlinear dynamical systems effects of homeopathic remedies on multiscale entropy and correlation dimension of slow wave sleep EEG in young adults with histories of coffee-induced insomnia. Homeopathy. 2012, 101 (3): 182-192.

  16. 16.

    Iavicoli I, Calabrese EJ, Nascarella MA: Exposure to nanoparticles and hormesis. Dose Response. 2010, 8 (4): 501-517.

  17. 17.

    Wiegant F, Van Wijk R: The similia principle: results obtained in a cellular model system. Homeopathy. 2010, 99 (1): 3-14.

  18. 18.

    Bell IR, Howerter A, Jackson N, Brooks AJ, Schwartz GE: Multi-week resting EEG cordance change patterns from repeated olfactory activation with two constitutionally-salient homeopathic remedies in healthy young adults. J Alternative and Complementary Medicine. 2012, 18 (5): 445-453.

  19. 19.

    Bellavite P, Signorini A: The Emerging Science of Homeopathy. Complexity, Biodynamics, and Nanopharmacology. 2002, Berkeley: North Atlantic Books, 2

  20. 20.

    Bellavite P: Complexity science and homeopathy: a synthetic overview. Homeopathy: the Journal of the Faculty of Homeopathy. 2003, 92 (4): 203-212.

  21. 21.

    Koithan M, Bell IR, Niemeyer K, Pincus D: A complex systems science perspective for whole systems of CAM research. Forsch Komplementarmed Klass Naturheilkd. 2012, 19 (Supplement 1): 7-14.

  22. 22.

    Bell IR, Koithan M, Pincus D: Research methodological implications of nonlinear dynamical systems models for whole systems of complementary and alternative medicine. Forsch Komplementarmed Klass Naturheilkd. 2012, 19 (Supplement 1): 15-21.

  23. 23.

    Pincus D, Metten A: Nonlinear dynamics in biopsychosocial resilience. Nonlinear Dynamics Psychol Life Sci. 2010, 14 (4): 353-380.

  24. 24.

    Rao ML, Roy R, Bell IR: The defining role of structure (including epitaxy) in the plausibility of homeopathy. Homeopathy. 2007, 96 (3): 175-182.

  25. 25.

    Chaplin MF: The Memory of Water: an overview. Homeopathy. 2007, 96 (3): 143-150.

  26. 26.

    Elia V, Napoli E, Germano R: The 'Memory of Water': an almost deciphered enigma. Dissipative structures in extremely dilute aqueous solutions. Homeopathy. 2007, 96 (3): 163-169.

  27. 27.

    Elia V, Niccoli M: Thermodynamics of extremely diluted aqueous solutions. Ann N Y Acad Sci. 1999, 879: 241-248.

  28. 28.

    Elia V, Niccoli M: New physico-chemical properties of extremely diluted aqueous solutions. Journal of Thermal Analysis and Calorimetry. 2004, 75: 815-836.

  29. 29.

    Rey L, Physica A: Thermoluminescence of ultra-high dilutions of lithium chloride and sodium chloride. Statistical mechanics and its applications. 2003, 323: 67-74.

  30. 30.

    Rey L: Can low-temperature thermoluminescence cast light on the nature of ultra-high dilutions?. Homeopathy. 2007, 96 (3): 170-174.

  31. 31.

    Roy R, Tiller W, Bell IR, Hoover MR: The structure of liquid water: novel insights from materials research and potential relevance to homeopathy. Materials Research Innovation. 2005, 9 (4): 557-608.

  32. 32.

    Demangeat JL: NMR relaxation evidence for solute-induced nanosized superstructures in ultramolecular aqueous dilutions of silica-lactose. Journal of Molecular Liquids. 2010, 155: 71-79.

  33. 33.

    Montagnier L, Aissa J, Ferris S, Montagnier J-L, Lavallee C: Electromagnetic signals are produced by aqueous nanostructures derived from bacterial DNA sequences. Interdisciplinary Sci Comput Life Sci. 2009, 1: 81-90.

  34. 34.

    Walach H: Entanglement model of homeopathy as an example of generalised entanglement predicted by weak quantum theory. Forschende Komplementarmedizin/Research in Complementary Medicine. 2003, 10 (4): 192-200.

  35. 35.

    Milgrom LR: A new geometrical description of entanglement and the curative homeopathic process. J Altern Complement Med. 2008, 14 (3): 329-339.

  36. 36.

    Calabrese EJ: Hormesis and homeopathy: introduction. Hum Exp Toxicol. 2010, 29 (7): 527-529.

  37. 37.

    Rattan SI, Deva T: Testing the hormetic nature of homeopathic interventions through stress response pathways. Hum Exp Toxicol. 2010, 29 (7): 551-554.

  38. 38.

    Calabrese EJ, Jonas WB: Homeopathy: clarifying its relationship to hormesis. Hum Exp Toxicol. 2010, 29 (7): 531-6. 29(7):531–536.

  39. 39.

    Bell IR, Schwartz GE: Adaptive network nanomedicine: an integrated model for homeopathic medicine. Frontiers in Bioscience (Elite Ed). 2012, in press.

  40. 40.

    Hahnemann S: Organon of the Medical Art. 1843, Redmond, WA: Birdcage Books, 6

  41. 41.

    Clarke JH: A Dictionary of Practical Materia Medica. 1977, Bradford, UK: Health Science Press

  42. 42.

    Steinsbekk A, Ludtke R: Patients' assessments of the effectiveness of homeopathic care in Norway: a prospective observational multicentre outcome study. Homeopathy. 2005, 94 (1): 10-16.

  43. 43.

    Kliems H, Witt CM: The good doctor: a qualitative study of German homeopathic physicians. J Altern Complement Med. 2011, 17 (3): 265-270.

  44. 44.

    New Directions in Homeopathy Research. Edited by: Witt C, Albrecht H. 2009, Essen, Germany: KVC Verlag

  45. 45.

    Bornhoft G, Matthiessen PF: Homeopathy in Healthcare – Effectiveness. 2011, Appropriateness, Safety, Costs: Springer

  46. 46.

    Jutte R, Riley D: A review of the use and role of low potencies in homeopathy. Complement Ther Med. 2005, 13 (4): 291-296.

  47. 47.

    Loftsson T: Aqueous solubility and true solutions. Pharmazie. 2010, 65 (6): 404-407.

  48. 48.

    Roduner E: Size matters: why nanomaterials are different. Chem Soc Rev. 2006, 35 (7): 583-592.

  49. 49.

    DeCastro CL, Mitchell BS: Nanoparticles from mechanical attrition. Synthesis, Functionalization, and Surface Treatment of Nanoparticles. Edited by: Baraton MI. 2002, Valencia, CA: American Scientific Publisher, 1-15.

  50. 50.

    Merisko-Liversidge E, Liversidge GG: Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv Drug Deliv Rev. 2011, 63 (6): 427-440.

  51. 51.

    Keck CM, Muller RH: Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm. 2006, 62 (1): 3-16.

  52. 52.

    Liu G, Zhang D, Jiao Y, Zheng D, Liu Y, Duan C, Jia L, Zhang Q, Lou H: Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology. Int J Pharm. 2012, 422 (1–2): 516-522.

  53. 53.

    Ruan B, Jacobi M: Ultrasonication effects on thermal and rheological properties of carbon nanotube suspensions. Nanoscale Res Lett. 2012, 7 (1): 127-

  54. 54.

    Tang C, Zhou T, Yang J, Zhang Q, Chen F, Fu Q, Yang L: Wet-grinding assisted ultrasonic dispersion of pristine multi-walled carbon nanotubes (MWCNTs) in chitosan solution. Colloids Surf B Biointerfaces. 2011, 86 (1): 189-197.

  55. 55.

    Chan HK, Kwok PC: Production methods for nanodrug particles using the bottom-up approach. Adv Drug Deliv Rev. 2011, 63 (6): 406-416.

  56. 56.

    Liu L, Randolph TW, Carpenter JF: Particles shed from syringe filters and their effects on agitation-induced protein aggregation. J Pharm Sci. 2012, 101 (8): 2952-2959.

  57. 57.

    Fratini E, Page MG, Giorgi R, Colfen H, Baglioni P, Deme B, Zemb T: Competitive surface adsorption of solvent molecules and compactness of agglomeration in calcium hydroxide nanoparticles. Langmuir. 2007, 23 (5): 2330-2338.

  58. 58.

    Abbasi AR, Morsali A: Influence of solvents on the morphological properties of AgBr nano-structures prepared using ultrasound irradiation. Ultrason Sonochem. 2012, 19 (3): 540-545.

  59. 59.

    Chi EY, Weickmann J, Carpenter JF, Manning MC, Randolph TW: Heterogeneous nucleation-controlled particulate formation of recombinant human platelet-activating factor acetylhydrolase in pharmaceutical formulation. J Pharm Sci. 2005, 94 (2): 256-274.

  60. 60.

    Buzea C, Pacheco II, Robbie K: Nanomaterials and nanoparticles: sources and toxicity. Biointerphases. 2007, 2 (4): MR17-71.

  61. 61.

    Yao P, Hughes S: Macroscopic entanglement and violation of Bell's inequalities between two spatially separated quantum dots in a planar photonic crystal system. Opt Express. 2009, 17 (14): 11505-11514.

  62. 62.

    Bhattacharyya SS, Paul S, Khuda-Bukhsh AR: Encapsulated plant extract (Gelsemium sempervirens) poly (lactide-co-glycolide) nanoparticles enhance cellular uptake and increase bioactivity in vitro. Exp Biol Med (Maywood). 2010, 235 (6): 678-688.

  63. 63.

    Prakash DJ, Arulkumar S, Sabesan M: Effect of nanohypericum (Hypericum perforatum gold nanoparticles) treatment on restraint stress induced behavioral and biochemical alteration in male albino mice. Pharmacognosy Res. 2010, 2 (6): 330-334.

  64. 64.

    Das S, Das J, Samadder A, Bhattacharyya S, Das D, Khuda-Bukhsh AR: Biosynthesized silver nanoparticles by ethanolic extracts of Phytolacca decandra, Gelsemium sempervirens, Hydrastis canadensis and Thuja occidentalis induce differential cytotoxicity through G2/M arrest in A375 cells. Colloids Surf B Biointerfaces. 2013, 101: 325-336.

  65. 65.

    Song L, Yang K, Jiang W, Du P, Xing B: Adsorption of bovine serum albumin on nano and bulk oxide particles in deionized water. Colloids Surf B Biointerfaces. 2012, 94: 341-346.

  66. 66.

    Tavares Cardoso MA, Talebi M, Soares PA, Yurteri CU, van Ommen JR: Functionalization of lactose as a biological carrier for bovine serum albumin by electrospraying. Int J Pharmaceutics. 2011, 414 (1–2): 1-5.

  67. 67.

    Belton DJ, Deschaume O, Perry CC: An overview of the fundamentals of the chemistry of silica with relevance to biosilicification and technological advances. FEBS J. 2012, 279 (10): 1710-1720.

  68. 68.

    Nair HB, Sung B, Yadav VR, Kannappan R, Chaturvedi MM, Aggarwal BB: Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochem Pharmacol. 2010, 80 (12): 1833-1843.

  69. 69.

    Bhattacharyya SS, Das J, Das S, Samadder A, Das D, De A, Paul S, Khuda-Bukhsh AR: Rapid green synthesis of silver nanoparticles from silver nitrate by a homeopathic mother tincture Phytolacca Decandra. Zhong Xi Yi Jie He Xue Bao. 2012, 10 (5): 546-554.

  70. 70.

    Patil SV, Borase HP, Patil CD, Salunke BK: Biosynthesis of silver nanoparticles using latex from few euphorbian plants and their antimicrobial potential. Appl Biochem Biotechnol. 2012, 167 (4): 776-790.

  71. 71.

    Perry CC, Keeling-Tucker T: Crystalline silica prepared at room temperature from aqueous solution in the presence of intrasilica bioextracts. Chem Commun (Camb). 1998, 1998 (23): 2587-2588.

  72. 72.

    Perry CC, Keeling-Tucker T: Model studies of colloidal silica precipitation using biosilica extracts from Equisetum telmateia. Colloid Polym Sci. 2003, 281 (7): 652-664.

  73. 73.

    Daisy P, Saipriya K: Biochemical analysis of Cassia fistula aqueous extract and phytochemically synthesized gold nanoparticles as hypoglycemic treatment for diabetes mellitus. Int J Nanomedicine. 2012, 7: 1189-1202.

  74. 74.

    Witt CM, Ludtke R, Weisshuhn TE, Quint P, Willich SN: The role of trace elements in homeopathic preparations and the influence of container material, storage duration, and potentisation. Forsch Komplementarmed. 2006, 13 (1): 15-21.

  75. 75.

    Khripin CY, Pristinski D, Dunphy DR, Brinker CJ, Kaehr B: Protein-directed assembly of arbitrary three-dimensional nanoporous silica architectures. ACS Nano. 2011, 5 (2): 1401-1409.

  76. 76.

    Wang DC, Chen GY, Chen KY, Tsai CH: DNA as a template in self-assembly of Au nano-structure. IET Nanobiotechnol. 2011, 5 (4): 132-135.

  77. 77.

    Baca HK, Carnes EC, Ashley CE, Lopez DM, Douthit C, Karlin S, Brinker CJ: Cell-directed-assembly: directing the formation of nano/bio interfaces and architectures with living cells. Biochim Biophys Acta. 2011, 1810 (3): 259-267.

  78. 78.

    Neville F, Broderick MJ, Gibson T, Millner PA: Fabrication and activity of silicate nanoparticles and nanosilicate-entrapped enzymes using polyethyleneimine as a biomimetic polymer. Langmuir. 2011, 27 (1): 279-285.

  79. 79.

    Caron V, Willart JF, Lefort R, Derollez P, Danede F, Descamps M: Solid state amorphization kinetic of alpha lactose upon mechanical milling. Carbohydr Res. 2011, 346 (16): 2622-2628.

  80. 80.

    Schroder HC, Wang X, Tremel W, Ushijima H, Muller WE: Biofabrication of biosilica-glass by living organisms. Nat Prod Rep. 2008, 25 (3): 455-474.

  81. 81.

    Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, Latz E: Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008, 9 (8): 847-856.

  82. 82.

    Winter M, Beer HD, Hornung V, Kramer U, Schins RP, Forster I: Activation of the inflammasome by amorphous silica and TiO2 nanoparticles in murine dendritic cells. Nanotoxicology. 2011, 5 (3): 326-340.

  83. 83.

    Relaix S, Leheny RL, Reven L, Sutton M: Memory effect in composites of liquid crystal and silica aerosil. Phys Rev E Stat Nonlin Soft Matter Phys. 2011, 84 (6–1): 061705-

  84. 84.

    de Jonge N, Ross FM: Electron microscopy of specimens in liquid. Nat Nanotechnol. 2011, 6 (11): 695-704.

  85. 85.

    Ponce A, Mejia-Rosales S, Jose-Yacaman M: Scanning transmission electron microscopy methods for the analysis of nanoparticles. Methods Mol Biol. 2012, 906: 453-471.

  86. 86.

    Anick DJ: High sensitivity 1H-NMR spectroscopy of homeopathic remedies made in water. BMC Complement Altern Med. 2004, 4 (1): 1-

  87. 87.

    White ER, Mecklenburg M, Shevitski B, Singer SB, Regan BC: Charged nanoparticle dynamics in water induced by scanning transmission electron microscopy. Langmuir. 2012, 28 (8): 3695-3698.

  88. 88.

    Bell NC, Minelli C, Tompkins J, Stevens MM, Shard AG: Emerging techniques for submicrometer particle sizing applied to stober silica. Langmuir. 2012, 28 (29): 10860-10872.

  89. 89.

    Soo CY, Song Y, Zheng Y, Campbell EC, Riches AC, Gunn-Moore F, Powis SJ: Nanoparticle tracking analysis monitors microvesicle and exosome secretion from immune cells. Immunology. 2012, 136 (2): 192-197.

  90. 90.

    Armstead AL, Li B: Nanomedicine as an emerging approach against intracellular pathogens. Int J Nanomedicine. 2011, 6: 3281-3293.

  91. 91.

    Bershteyn A, Hanson MC, Crespo MP, Moon JJ, Li AV, Suh H, Irvine DJ: Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine. J Control Release. 2012, 157 (3): 354-365.

  92. 92.

    Barabasi AL, Gulbahce N, Loscalzo J: Network medicine: a network-based approach to human disease. Nat Rev Genet. 2011, 12 (1): 56-68.

  93. 93.

    Szalay MS, Kovacs IA, Korcsmaros T, Bode C, Csermely P: Stress-induced rearrangements of cellular networks: Consequences for protection and drug design. FEBS Lett. 2007, 581 (19): 3675-3680.

  94. 94.

    Brodsky SV, Goligorsky MS: Endothelium under stress: local and systemic messages. Semin Nephrol. 2012, 32 (2): 192-198.

  95. 95.

    Danese A, McEwen BS: Adverse childhood experiences, allostasis, allostatic load, and age-related disease. Physiol Behav. 2012, 106 (1): 29-39.

  96. 96.

    Demirovic D, Rattan SI: Establishing cellular stress response profiles as biomarkers of homeodynamics, health and hormesis. Exp Gerontol. 2012, In press.

  97. 97.

    Antelman SM, Caggiula AR, Gershon S, Edwards DJ, Austin MC, Kiss S, Kocan D: Stressor-induced oscillation. A possible model of the bidirectional symptoms in PTSD. Ann N Y Acad Sci. 1997, 821: 296-304.

  98. 98.

    Antelman SM, Caggiula AR, Kocan D, Knopf S, Meyer D, Edwards DJ, Barry H: One experience with 'lower' or 'higher' intensity stressors, respectively enhances or diminishes responsiveness to haloperidol weeks later: implications for understanding drug variability. Brain Res. 1991, 566 (1–2): 276-283.

  99. 99.

    West B: Where Medicine Went Wrong: Rediscovering the Path to Complexity (Studies of Nonlinear Phenomena in Life Science). 2006, New Jersey: World Scientific Publishing Company, 283-314.

  100. 100.

    Goldberger AL, Amaral LAN, Hausdorff JM, Ivanov PC, Peng CK, Stanley HE: Fractal dynamics in physiology: alterations with disease and aging. Proc Natl Acad Sci. 2002, 99 (Suppl 1): 2466-2472.

  101. 101.

    Vidal M, Cusick ME, Barabasi AL: Interactome networks and human disease. Cell. 2011, 144: 986-998.

  102. 102.

    Yoo JW, Yun DS, Kim HJ: Influence of reaction parameters on size and shape of silica nanoparticles. J Nanosci Nanotechnol. 2006, 6 (11): 3343-3346.

  103. 103.

    Song M, Yuan S, Yin J, Wang X, Meng Z, Wang H, Jiang G: Size-dependent toxicity of nano-C60 aggregates: more sensitive indication by apoptosis-related Bax translocation in cultured human cells. Environ Sci Technol. 2012, 46 (6): 3457-3464.

  104. 104.

    Yang X, Liu J, He H, Zhou L, Gong C, Wang X, Yang L, Yuan J, Huang H, He L: SiO2 nanoparticles induce cytotoxicity and protein expression alteration in HaCaT cells. Part Fibre Toxicol. 2010, 7: 1-

  105. 105.

    Napierska D, Thomassen LC, Rabolli V, Lison D, Gonzalez L, Kirsch-Volders M, Martens JA, Hoet PH: Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small. 2009, 5 (7): 846-853.

  106. 106.

    Passagne I, Morille M, Rousset M, Pujalte I, L'Azou B: Implication of oxidative stress in size-dependent toxicity of silica nanoparticles in kidney cells. Toxicology. 2012, 299 (2–3): 112-124.

  107. 107.

    Shi Z, Huang X, Liu B, Tao H, Cai Y, Tang R: Biological response of osteosarcoma cells to size-controlled nanostructured hydroxyapatite. J Biomater Appl. 2010, 25 (1): 19-37.

  108. 108.

    Pathak S, Multani AS, Banerji P, Banerji P: Ruta 6 selectively induces cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: A novel treatment for human brain cancer. Int J Oncol. 2003, 23 (4): 975-982.

  109. 109.

    Nandy P, Bhandary S, Das S, Basu R, Bhattacharya S: Nanoparticles and membrane anisotropy. Homeopathy. 2011, 100 (3): 194-

  110. 110.

    O'Connor TL, Greenberg SA: The kinetics for the solution of silica in aqueous solutions. J Phys Chem. 1958, 62 (10): 1195-1198.

  111. 111.

    Konakanchi H, Vajjha R, Misra D, Das D: Electrical conductivity measurements of nanofluids and development of new correlations. J Nanosci Nanotechnol. 2011, 11 (8): 6788-6795.

  112. 112.

    Liu Y, Kathan K, Saad W, Prudhomme RK: Ostwald ripening of B-carotene nanoparticles. Phys Rev Lett. 2007, 98 (035102): 1-4.

  113. 113.

    Mahesh S, Gopal A, Thirumalai R, Ajayaghosh A: Light-induced Ostwald ripening of organic nanodots to rods. J Am Chem Soc. 2012, 134 (17): 7227-7230.

  114. 114.

    Xin HL, Zheng H: In situ Observation of Oscillatory Growth of Bismuth Nanoparticles. Nano Lett. 2012, 12 (3): 1470-1474.

  115. 115.

    Wang Y, Wu X, Yang W, Zhai Y, Xie B, Yang M: Aggregate of nanoparticles: rheological and mechanical properties. Nanoscale Res Lett. 2011, 6 (1): 114-

  116. 116.

    Wolf U, Wolf M, Heusser P, Thurneysen A, Baumgartner S: Homeopathic preparations of quartz. sulfur and copper sulfate assessed by uv-spectroscopy. Evid Based Complement Alternat Med. 2011, 2011: 692798-

  117. 117.

    Witt C, Ludtke R, Weisshuhn TE, Willich SN: High homeopathic potencies are different from potentized solvent when investigated with the REDEM technology. Forsch Komplementarmed Klass Naturheilkd. 2005, 12 (1): 6-13.

  118. 118.

    Bell IR, Lewis D, Brooks AJ, Lewis S, Schwartz GE: Gas discharge visualization evaluation of ultramolecular doses of homeopathic medicines under blinded, controlled conditions. J Altern Complement Med. 2003, 9 (1): 25-38.

  119. 119.

    Sukul NC, Ghosh S, Sukul A, Sinhababu SP: Variation in Fourier transform infrared spectra of some homeopathic potencies and their diluent media. J Altern Complement Med. 2005, 11 (5): 807-812.

  120. 120.

    Ive EC, Couchman IM, Reddy L: Therapeutic effect of Arsenicum album on leukocytes. Int J Mol Sci. 2012, 13 (3): 3979-3987.

  121. 121.

    Gariboldi S, Palazzo M, Zanobbio L, Dusio GF, Mauro V, Solimene U, Cardani D, Mantovani M, Rumio C: Low dose oral administration of cytokines for treatment of allergic asthma. Pulm Pharmacol Ther. 2009, 22 (6): 497-510.

  122. 122.

    Samal A, Geckeler KE: Unexpected solute aggregation in water on dilution. Chem Commun. 2001, 2001 (21): 2224-2225.

  123. 123.

    Baumgartner S: The State of Basic Research on Homeopathy. New Directions in Homeopathy Research. Edited by: Witt C, Albrecht H. 2009, Essen, Germany: KVC Verlag, 107-130.

  124. 124.

    Baumgartner S, Shah D, Schaller J, Kampfer U, Thurneysen A, Heusser P: Reproducibility of dwarf pea shoot growth stimulation by homeopathic potencies of gibberellic acid. Complement Ther Med. 2008, 16 (4): 183-191.

  125. 125.

    Dantas F, Rampes H: Do homeopathic medicines provoke adverse effects? A systematic review. Br Homeopath J. 2000, 89 (Suppl 1): S35-S38.

  126. 126.

    Tesson B, Hildebrand M: Dynamics of silica cell wall morphogenesis in the diatom Cyclotella cryptica: substructure formation and the role of microfilaments. J Struct Biol. 2010, 169 (1): 62-74.

  127. 127.

    Li X, Zhang J, Gu H: Study on the adsorption mechanism of DNA with mesoporous silica nanoparticles in aqueous solution. Langmuir. 2012, 28 (5): 2827-2834.

  128. 128.

    Mohamed BM, Verma NK, Prina-Mello A, Williams Y, Davies AM, Bakos G, Tormey L, Edwards C, Hanrahan J, Salvati A: Activation of stress-related signalling pathway in human cells upon SiO2 nanoparticles exposure as an early indicator of cytotoxicity. J Nanobiotechnology. 2011, 9: 29-

  129. 129.

    Han B, Guo J, Abrahaley T, Qin L, Wang L, Zheng Y, Li B, Liu D, Yao H, Yang J: Adverse effect of nano-silicon dioxide on lung function of rats with or without ovalbumin immunization. PLoS One. 2011, 6 (2): e17236-

  130. 130.

    Zhu M, Li Y, Shi J, Feng W, Nie G, Zhao Y: Exosomes as extrapulmonary signaling conveyors for nanoparticle-induced systemic immune activation. Small. 2012, 8 (3): 404-412.

  131. 131.

    Khuda-Bukhsh AR, De A, Das D, Dutta S, Boujedaini N: Analysis of the capability of ultra-highly diluted glucose to increase glucose uptake in arsenite-stressed bacteria Escherichia coli. Zhong Xi Yi Jie He Xue Bao. 2011, 9 (8): 901-912.

  132. 132.

    Sunila ES, Hamsa TP, Kuttan G: Effect of Thuja occidentalis and its polysaccharide on cell-mediated immune responses and cytokine levels of metastatic tumor-bearing animals. Pharm Biol. 2011, 49 (10): 1065-1073.

  133. 133.

    Sunila ES, Kuttan R, Preethi KC, Kuttan G: Dynamized preparations in cell culture. Evid Based Complement Alternat Med. 2009, 6 (2): 257-263.

  134. 134.

    McEwen BS: Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. 2007, 87 (3): 873-904.

  135. 135.

    Gadek-Michalska A, Bugajski J: Interleukin-1 (IL-1) in stress-induced activation of limbic-hypothalamic-pituitary adrenal axis. Pharmacol Rep. 2010, 62 (6): 969-982.

  136. 136.

    Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP: Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation. 2005, 12 (5): 255-269.

  137. 137.

    Matsumoto M, Fujii Y, Baba A, Hikida M, Kurosaki T, Baba Y: The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production. Immunity. 2011, 34 (5): 703-714.

  138. 138.

    Scharpf KR, Wendt J, Lotze M, Hamm AO: The brain's relevance detection network operates independently of stimulus modality. Behav Brain Res. 2010, 210 (1): 16-23.

  139. 139.

    Bell IR, Lewis DA, Schwartz GE, Lewis SE, Caspi O, Scott A, Brooks AJ, Baldwin CM: Electroencephalographic cordance patterns distinguish exceptional clinical responders with fibromyalgia to individualized homeopathic medicines. J Alternative & Complementary Medicine. 2004, 10 (2): 285-299.

  140. 140.

    Soboloff J, Madesh M, Gill DL: Sensing cellular stress through STIM proteins. Nat Chem Biol. 2011, 7 (8): 488-492.

  141. 141.

    Calabrese V, Cornelius C, Dinkova-Kostova AT, Iavicoli I, Di Paola R, Koverech A, Cuzzocrea S, Rizzarelli E, Calabrese EJ: Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity. Biochim Biophys Acta. 2012, 1822 (5): 753-783.

  142. 142.

    Mihalik A, Csermely P: Heat shock partially dissociates the overlapping modules of the yeast protein-protein interaction network: a systems level model of adaptation. PLoS Comput Biol. 2011, 7 (10): e1002187-

  143. 143.

    Vasquez A, Dobrin R, Sergi D, Eckmann JP, Oltvai ZN, Barabasi AL: The topological relationship between the large-scale attributes and local interaction patterns of complex networks. Proc Natl Acad Sci USA. 2004, 101 (52): 17940-17945.

  144. 144.

    Csermely P: Chaperone overload is a possible contributor to 'civilization diseases'. Trends Genet. 2001, 17 (12): 701-704.

  145. 145.

    Koithan M, Verhoef M, Bell IR, Ritenbaugh C, White M, Mulkins A: The process of whole person healing: "unstuckness" and beyond. J Altern Complement Med. 2007, 13 (6): 659-668.

  146. 146.

    Van Wijk R, Wiegant FA: The similia principle as a therapeutic strategy: a research program on stimulation of self-defense in disordered mammalian cells. Altern Ther Health Med. 1997, 3 (2): 33-38.

  147. 147.

    Ramachandran C, Nair PK, Clement RT, Melnick SJ: Investigation of cytokine expression in human leukocyte cultures with two immune-modulatory homeopathic preparations. J Altern Complement Med. 2007, 13 (4): 403-407.

  148. 148.

    Glatthaar-Saalmuller B: In vitro evaluation of the antiviral effects of the homeopathic preparation Gripp-Heel on selected respiratory viruses. Can J Physiol Pharmacol. 2007, 85 (11): 1084-1090.

  149. 149.

    Roeska K, Seilheimer B: Antiviral activity of Engystol(R) and Gripp-Heel(R): an in-vitro assessment. J Immune Based Ther Vaccines. 2010, 8: 6-

  150. 150.

    Pereira WK, Lonardoni MV, Grespan R, Caparroz-Assef SM, Cuman RK, Bersani-Amado CA: Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection. J Infect. 2005, 51 (2): 157-164.

  151. 151.

    Burbano RR, Leal MF, da Costa JB, Bahia Mde O, de Lima PD, Khayat AS, Seligman IC, de Assumpcao PP, Buchi Dde F, Smith Mde A: Lymphocyte proliferation stimulated by activated human macrophages treated with Canova. Homeopathy. 2009, 98 (1): 45-48.

  152. 152.

    Smit E, Oberholzer HM, Pretorius E: A review of immunomodulators with reference to Canova. Homeopathy. 2009, 98 (3): 169-176.

  153. 153.

    Bellavite P, Marzotto M, Chirumbolo S, Conforti A: Advances in homeopathy and immunology: a review of clinical research. Front Biosci (Schol Ed). 2011, 3: 1363-1389.

  154. 154.

    Bell IR, Lewis DA, Lewis SE, Schwartz GE, Brooks AJ, Scott A, Baldwin CM: EEG alpha sensitization in individualized homeopathic treatment of fibromyalgia. Int J Neurosci. 2004, 114 (9): 1195-1220.

  155. 155.

    Bell IR, Howerter A, Jackson N, Aickin M, Baldwin CM, Bootzin RR: Effects of homeopathic medicines on polysomnographic sleep of young adults with histories of coffee-related insomnia. Sleep Med. 2011, 12 (5): 505-511.

  156. 156.

    Bell IR, Brooks AJ, Howerter A, Jackson N, Schwartz GE: Short term effects of repeated olfactory administration of homeopathic Sulphur or Pulsatilla on electroencephalographic alpha power in healthy young adults. Homeopathy. 2011, 100 (4): 203-211.

  157. 157.

    Ruiz-Vega G, Poitevin B, Perez-Ordaz L: Histamine at high dilution reduces spectral density in delta band in sleeping rats. Homeopathy. 2005, 94 (2): 86-91.

  158. 158.

    Magnani P, Conforti A, Zanolin E, Marzotto M, Bellavite P: Dose-effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice. Psychopharmacology (Berl). 2010, 210 (4): 533-545.

  159. 159.

    Bellavite P, Magnani P, Zanolin E, Conforti A: Homeopathic doses of Gelsemium sempervirens improve the behavior of mice in response to novel environments. Evid Based Complement Alternat Med. 2011, 2011: 362517-

  160. 160.

    Jonas W, Lin Y, Tortella F: Neuroprotection from glutamate toxicity with ultra-low dose glutamate. Neuroreport. 2001, 12 (2): 335-339.

  161. 161.

    Marotta D, Marini A, Banaudha K, Maharaj SV, Jonas WB: Nonlinear effects of glutamate and KCl on glutamate toxicity in cultured rat cerebellar neurons. Int J Neurosci. 2003, 113 (4): 491-502.

  162. 162.

    Mishra N, Muraleedharan KC, Paranjpe AS, Munta DK, Singh H, Nayak C: An exploratory study on scientific investigations in homeopathy using medical analyzer. J Altern Complement Med. 2011, 17 (8): 705-710.

  163. 163.

    Das D, De A, Dutta S, Biswas R, Boujedaini N, Khuda-Bukhsh AR: Potentized homeopathic drug Arsenicum Album 30C positively modulates protein biomarkers and gene expressions in Saccharomyces cerevisae exposed to arsenate. Zhong Xi Yi Jie He Xue Bao. 2011, 9 (7): 752-760.

  164. 164.

    de Oliveira CC, de Oliveira SM, Goes VM, Probst CM, Krieger MA, Buchi Dde F: Gene expression profiling of macrophages following mice treatment with an immunomodulator medication. J Cell Biochem. 2008, 104 (4): 1364-1377.

  165. 165.

    Tai W, Roberts L, Seryshev A, Gubatan JM, Bland CS, Zabriskie R, Kulkarni S, Soong L, Mbawuike I, Gilbert B: Multistrain influenza protection induced by a nanoparticulate mucosal immunotherapeutic. Mucosal Immunol. 2011, 4 (2): 197-207.

  166. 166.

    Marano F, Hussain S, Rodrigues-Lima F, Baeza-Squiban A, Boland S: Nanoparticles: molecular targets and cell signalling. Arch Toxicol. 2011, 85 (7): 733-741.

  167. 167.

    Hanley C, Thurber A, Hanna C, Punnoose A, Zhang J, Wingett DG: The influences of cell type and ZnO nanoparticle size on immune cell cytotoxicity and cytokine induction. Nanoscale Res Lett. 2009, 4: 1409-1420.

  168. 168.

    Kvetnansky R, Sabban EL, Palkovits M: Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol Rev. 2009, 89 (2): 535-606.

  169. 169.

    Sabban EL, Serova LI: Influence of prior experience with homotypic or heterotypic stressor on stress reactivity in catecholaminergic systems. Stress. 2007, 10 (2): 137-143.

  170. 170.

    Hayley S, Merali Z, Anisman H: Stress and cytokine-elicited neuroendocrine and neurotransmitter sensitization: implications for depressive illness. Stress. 2003, 6 (1): 19-32.

  171. 171.

    Lorton D, Lubahn CL, Estus C, Millar BA, Carter JL, Wood CA, Bellinger DL: Bidirectional communication between the brain and the immune system: implications for physiological sleep and disorders with disrupted sleep. Neuroimmunomodulation. 2006, 13 (5–6): 357-374.

  172. 172.

    Zhang H, He X, Zhang Z, Zhang P, Li Y, Ma Y, Kuang Y, Zhao Y, Chai Z: Nano-CeO2 exhibits adverse effects at environmental relevant concentrations. Environ Sci Technol. 2011, 45 (8): 3725-3730.

  173. 173.

    Wiegant FA, Prins HA, Van Wijk R: Postconditioning hormesis put in perspective: an overview of experimental and clinical studies. Dose Response. 2011, 9 (2): 209-224.

  174. 174.

    Lewin SR, Ribeiro RM, Walters T, Lau GK, Bowden S, Locarnini S, Perelson AS: Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed. Hepatology. 2001, 34 (5): 1012-1020.

  175. 175.

    Zilinskas J, Zekonis J, Zekonis G, Sadzeviciene R, Sapragoniene M, Navickaite J, Barzdziukaite I: Inhibition of peripheral blood neutrophil oxidative burst in periodontitis patients with a homeopathic medication Traumeel S. Med Sci Monit. 2011, 17 (5): CR284-CR291.

  176. 176.

    Wang T, Jiang H, Zhao Q, Wang S, Zou M, Cheng G: Enhanced mucosal and systemic immune responses obtained by porous silica nanoparticles used as an oral vaccine adjuvant: Effect of silica architecture on immunological properties. Int J Pharm. 2012, 436 (1–2): 351-358.

  177. 177.

    Davies PC: Does quantum mechanics play a non-trivial role in life?. Biosystems. 2004, 78 (1–3): 69-79.

  178. 178.

    McGuinness LP, Yan Y, Stacey A, Simpson DA, Hall LT, Maclaurin D, Prawer S, Mulvaney P, Wrachtrup J, Caruso F: Quantum measurement and orientation tracking of fluorescent nanodiamonds inside living cells. Nat Nanotechnol. 2011, 6 (6): 358-363.

  179. 179.

    Karmali PP, Simberg D: Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems. Expert Opin Drug Deliv. 2011, 8 (3): 343-357.

  180. 180.

    Antelman SM, Caggiula AR, Edwards DJ, Gershon S, Kucinski BJ, Kiss S, Kocan D: Long-term oscillation of corticosterone following intermittent cocaine. J Neural Transm Gen Sect. 2000, 107 (3): 369-375.

  181. 181.

    Abraham WC: Metaplasticity: tuning synapses and networks for plasticity. Nat Rev Neurosci. 2008, 9 (5): 387-

  182. 182.

    Hale HB: Cross-adaptation. Environ Res. 1969, 2: 423-434.

  183. 183.

    Loscalzo J, Barabasi AL: Systems biology and the future of medicine. Wiley Interdiscip Rev Syst Biol Med. 2011, 3 (6): 619-627.

  184. 184.

    Stebbing AR: A mechanism for hormesis–a problem in the wrong discipline. Crit Rev Toxicol. 2003, 33 (3–4): 463-467.

  185. 185.

    Artola A: Diabetes-, stress- and ageing-related changes in synaptic plasticity in hippocampus and neocortex–the same metaplastic process?. Eur J Pharmacol. 2008, 585 (1): 153-162.

  186. 186.

    Antelman SM, Caggiula AR: Oscillation follows drug sensitization: implications. Crit Rev Neurobiol. 1996, 10 (1): 101-117.

  187. 187.

    Antelman SM, Levine J, Gershon S: Time-dependent sensitization: the odyssey of a scientific heresy from the laboratory to the door of the clinic. Mol Psychiatry. 2000, 5 (4): 350-356.

  188. 188.

    Mattson MP: Hormesis defined. Aging Research Rev. 2008, 7 (1): 1-7.

  189. 189.

    Calabrese EJ, Mattson MP: Hormesis provides a generalized quantitative estimate of biological plasticity. J Cell Commun Signal. 2011, 5 (1): 25-38.

  190. 190.

    Nascarella MA, Calabrese EJ: A method to evaluate hormesis in nanoparticle dose-responses. Dose Response. 2012, 10 (3): 344-354.

  191. 191.

    Vaiserman AM: Hormesis, adaptive epigenetic reorganization, and implications for human health and longevity. Dose Response. 2010, 8 (1): 16-21.

  192. 192.

    Stebbing AR: Adaptive responses account for the beta-curve-hormesis is linked to acquired tolerance. Nonlinearity Biol Toxicol Med. 2003, 1 (4): 493-511.

  193. 193.

    Launay JC, Besnard Y, Guinet-Lebreton A, Savourey G: Acclimation to intermittent hypobaric hypoxia modifies responses to cold at sea level. Aviat Space Environ Med. 2006, 77 (12): 1230-1235.

  194. 194.

    Lunt HC, Barwood MJ, Corbett J, Tipton MJ: 'Cross-adaptation': habituation to short repeated cold-water immersions affects the response to acute hypoxia in humans. J Physiol. 2010, 588 (Pt 18): 3605-3613.

  195. 195.

    Adolph EF: General and specific characteristics of physiological adaptations. Am J Physiol. 1956, 184: 18-28.

  196. 196.

    Frei H: Polarity analysis, a new approach to increase the precision of homeopathic prescriptions. Homeopathy. 2009, 98 (1): 49-55.

  197. 197.

    Win-Shwe TT, Yamamoto S, Fujitani Y, Hirano S, Fujimaki H: Spatial learning and memory function-related gene expression in the hippocampus of mouse exposed to nanoparticle-rich diesel exhaust. Neurotoxicology. 2008, 29 (6): 940-947.

  198. 198.

    Wiegant FA, Spieker N, van Wijk R: Stressor-specific enhancement of hsp induction by low doses of stressors in conditions of self- and cross-sensitization. Toxicology. 1998, 127 (1–3): 107-119.

  199. 199.

    Karst H, Berger S, Erdmann G, Schutz G, Joels M: Metaplasticity of amygdalar responses to the stress hormone corticosterone. Proc Natl Acad Sci USA. 2010, 107 (32): 14449-14454.

  200. 200.

    Bliem B, Muller-Dahlhaus JF, Dinse HR, Ziemann U: Homeostatic metaplasticity in the human somatosensory cortex. J Cogn Neurosci. 2008, 20 (8): 1517-1528.

  201. 201.

    Potter-Nerger M, Fischer S, Mastroeni C, Groppa S, Deuschl G, Volkmann J, Quartarone A, Munchau A, Siebner HR: Inducing homeostatic-like plasticity in human motor cortex through converging corticocortical inputs. J Neurophysiol. 2009, 102 (6): 3180-3190.

  202. 202.

    Garcia R, Spennato G, Nilsson-Todd L, Moreau JL, Deschaux O: Hippocampal low-frequency stimulation and chronic mild stress similarly disrupt fear extinction memory in rats. Neurobiol Learn Mem. 2008, 89 (4): 560-566.

  203. 203.

    Marotta D, Marini A, Banaudha K, Maharaj S, Jonas WB: Nonlinear effects of glutamate and KCl on glutamate toxicity in cultured rat cerebellar neurons. Int J Neurosci. 2003, 113: 45-56.

  204. 204.

    Antal A, Begemeier S, Nitsche MA, Paulus W: Prior state of cortical activity influences subsequent practicing of a visuomotor coordination task. Neuropsychologia. 2008, 46 (13): 3157-3161.

  205. 205.

    Avena NM, Rada P, Hoebel BG: Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci Biobehav Rev. 2008, 32 (1): 20-39.

  206. 206.

    Antelman SM, Eichler AJ, Black CA, Kocan D: Interchangeability of stress and amphetamine in sensitization. Science. 1980, 207 (4428): 329-331.

  207. 207.

    Frank MG, Watkins LR, Maier SF: Stress- and glucocorticoid-induced priming of neuroinflammatory responses: Potential mechanisms of stress-induced vulnerability to drugs of abuse. Brain Behav Immun. 2011, 25 (Suppl1): S21-28.

  208. 208.

    Sorg B, Bailie T, Tschirgi M, Li N, Wu W: Exposure to repeated low-level formaldehyde in rats increases basal corticosterone levels and enhances the corticosterone response to subsequent formaldehyde. Brain Res. 2001, 898 (2): 314-320.

  209. 209.

    Prasad BM, Ulibarri C, Sorg BA: Stress-induced cross-sensitization to cocaine: effect of adrenalectomy and corticosterone after short- and long-term withdrawal. Psychopharmacology. 1998, 136 (1): 24-33.

  210. 210.

    Rada P, Avena NM, Hoebel BG: Daily bingeing on sugar repeatedly releases dopamine in the accumbens shell. Neuroscience. 2005, 134 (3): 737-744.

  211. 211.

    Avena NM, Hoebel BG: Amphetamine-sensitized rats show sugar-induced hyperactivity (cross-sensitization) and sugar hyperphagia. Pharmacol Biochem Behav. 2003, 74 (3): 635-639.

  212. 212.

    Sorg BA, Tschirgi ML, Swindell S, Chen L, Fang J: Repeated formaldehyde effects in an animal model for multiple chemical sensitivity. [Review] [56 refs]. Ann N Y Acad Sci. 2001, 933: 57-67.

  213. 213.

    Xu GP, Van Bockstaele E, Reyes B, Bethea T, Valentino RJ: Chronic morphine sensitizes the brain norepinephrine system to corticotropin-releasing factor and stress. J Neurosci. 2004, 24 (38): 8193-8197.

  214. 214.

    Antelman SM, Knopf S, Kocan D, Edwards DJ, Ritchie JC, Nemeroff CB: One stressful event blocks multiple actions of diazepam for up to at least a month. Brain Res. 1988, 445 (2): 380-385.

  215. 215.

    Bortolotto ZA, Collett VJ, Conquet F, Jia Z, Collingridge GL: An analysis of the stimulus requirements for setting the molecular switch reveals a lower threshold for metaplasticity than synaptic plasticity. Neuropharmacology. 2008, 55 (4): 454-458.

  216. 216.

    Antelman S: Stress and its timing: critical factors in determining the consequences of dopaminergic agents. Pharmacol Biochem Behav. 1982, 17 (Suppl 1): 21-23.

  217. 217.

    Antelman SM, Caggiula AR, Kiss S, Edwards DJ, Kocan D, Stiller R: Neurochemical and physiological effects of cocaine oscillate with sequential drug treatment: possibly a major factor in drug variability. Neuropsychopharmacology. 1995, 12 (4): 297-306.

  218. 218.

    Antelman SM, Caggiula AR, Knopf S, Kocan DJ, Edwards DJ: Amphetamine or haloperidol 2 weeks earlier antagonized the plasma corticosterone response to amphetamine; evidence for the stressful/foreign nature of drugs. Psychopharmacology. 1992, 107 (2–3): 331-336.

  219. 219.

    Stub T, Salamonsen A, Alraek T: Is it possible to distinguish homeopathic aggravation from adverse effects? A qualitative study. Forsch Komplementmed. 2012, 19 (1): 13-19.

  220. 220.

    Oberbaum M, Singer SR, Vithoulkas G: The colour of the homeopathic improvement: the multidimensional nature of the response to homeopathic therapy. Homeopathy. 2005, 94 (3): 196-199.

  221. 221.

    Woolf CJ: Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011, 152 (3 Suppl): S2-S15.

  222. 222.

    Bell IR, Lewis DAI, Brooks AJ, Schwartz GE, Lewis SE, Walsh BT, Baldwin CM: Improved clinical status in fibromyalgia patients treated with individualized homeopathic remedies versus placebo. Rheumatology. 2004, 43: 577-582.

  223. 223.

    Bell IR, Lewis DA, Schwartz GE, Lewis SE, Caspi O, Scott A, Brooks AJ, Baldwin CM: Electroencephalographic cordance patterns distinguish exceptional clinical responders with fibromyalgia to individualized homeopathic medicines. J Altern Complement Med. 2004, 10 (2): 285-299.

  224. 224.

    Vithoulkas G: The Science of Homeopathy. 1980, N.Y.: Grove Weidenfeld

  225. 225.

    Singh SK, Srinivasan KK, Gowthamarajan K, Singare DS, Prakash D, Gaikwad NB: Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide. Eur J Pharm Biopharm. 2011, 78 (3): 441-446.

  226. 226.

    Schiff SJ, Jerger K, Duong DH, Chang T, Spano ML, Ditto WL: Controlling chaos in the brain. Nature. 1994, 370: 615-620.

  227. 227.

    Garfinkel A, Spano ML, Ditto WL, Weiss JN: Controlling cardiac chaos. Science. 1992, 257 (5074): 1230-1235.

  228. 228.

    Coffey DS: Self-organization, complexity, and chaos: the new biology for medicine. Nat Med. 1998, 4 (8): 882-885.

  229. 229.

    Avena NM, Rada P, Moise N, Hoebel BG: Sucrose sham feeding on a binge schedule releases accumbens dopamine repeatedly and eliminates the acetylcholine satiety response. Neuroscience. 2006, 139 (3): 813-820.

  230. 230.

    Chae Y, Yang CH, Kwon YK, Kim MR, Pyun KH, Hahm DH, Lee HJ, Shim I: Acupuncture attenuates repeated nicotine-induced behavioral sensitization and c-Fos expression in the nucleus accumbens and striatum of the rat. Neurosci Lett. 2004, 358: 87-90.

  231. 231.

    Curran EJ, Akil H, Watson SJ: Psychomotor stimulant- and opiate-induced c-fos mRNA expression patterns in the rat forebrain: comparisons between acute drug treatment and a drug challenge in sensitized animals. Neurochem Res. 1996, 21 (11): 1425-1435.

  232. 232.

    Day HE, Badiani A, Uslaner JM, Oates MM, Vittoz NM, Robinson TE, Watson SJ, Akil H: Environmental novelty differentially affects c-fos mRNA expression induced by amphetamine or cocaine in subregions of the bed nucleus of the stria terminalis and amygdala. J Neurosci. 2001, 21 (2): 732-740.

  233. 233.

    Lee BR, Dong Y: Cocaine-induced metaplasticity in the nucleus accumbens: silent synapse and beyond. Neuropharmacology. 2011, 61 (7): 1060-1069.

  234. 234.

    Seery MD, Leo RJ, Holman EA, Silver RC: Lifetime exposure to adversity predicts functional impairment and healthcare utilization among individuals with chronic back pain. Pain. 2010, 150 (3): 507-515.

  235. 235.

    Kauffman S: At Home in the Universe. The Search for the Laws of Self-Organization and Complexity. 1995, NY: Oxford University Press

  236. 236.

    Fredrickson BL, Losada MF: Positive affect and the complex dynamics of human flourishing. Am Psychol. 2005, 60 (7): 678-686.

  237. 237.

    Bell IR, Koithan M: Models for the study of whole systems. Integr Cancer Ther. 2006, 5 (4): 293-307.

  238. 238.

    Brien SB, Harrison H, Daniels J, Lewith G: Monitoring improvement in health during homeopathic intervention. Development of an assessment tool based on Hering's Law of Cure: the Hering's Law Assessment Tool (HELAT). Homeopathy. 2012, 101 (1): 28-37.

  239. 239.

    Besinis A, van Noort R, Martin N: Infiltration of demineralized dentin with silica and hydroxyapatite nanoparticles. Dental materials: official publication of the Academy of Dental Materials. 2012, 28 (9): 1012-1023.

  240. 240.

    Randolph T: Specific adaptation. Ann Allergy. 1978, 40: 333-345.

  241. 241.

    Bar-Yam Y, Epstein IR: Response of complex networks to stimuli. Proc Natl Acad Sci USA. 2004, 101 (13): 4341-4345.

  242. 242.

    Kim J, Arola DD, Gu L, Kim YK, Mai S, Liu Y, Pashley DH, Tay FR: Functional biomimetic analogs help remineralize apatite-depleted demineralized resin-infiltrated dentin via a bottom-up approach. Acta Biomater. 2010, 6 (7): 2740-2750.

  243. 243.

    Sukul NC, Bala SK, Bhattacharyya B: Prolonged cataleptogenic effects of potentized homoeopathic drugs. Psychopharmacology. 1986, 89: 338-339.

  244. 244.

    Verma S, Gokhale R, Burgess DJ: A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions. Int J Pharm. 2009, 380 (1–2): 216-222.

  245. 245.

    Liu Y, Lou C, Yang H, Shi M, Miyoshi H: Silica nanoparticles as promising drug/gene delivery carriers and fluorescent nano-probes: recent advances. Curr Cancer Drug Targets. 2011, 11 (2): 156-163.

  246. 246.

    Hardy CL, LeMasurier JS, Belz GT, Scalzo-Inguanti K, Yao J, Xiang SD, Kanellakis P, Bobik A, Strickland DH, Rolland JM: Inert 50-nm polystyrene nanoparticles that modify pulmonary dendritic cell function and inhibit allergic airway inflammation. J Immunol. 2012, 188 (3): 1431-1441.

  247. 247.

    Zhang Q, Pi J, Woods CG, Andersen ME: Phase I to II cross-induction of xenobiotic metabolizing enzymes: a feedforward control mechanism for potential hormetic responses. Toxicol Appl Pharmacol. 2009, 237 (3): 345-356.

  248. 248.

    Rozman KK, Doull J: Scientific foundations of hormesis. Part 2. Maturation, strengths, limitations, and possible applications in toxicology, pharmacology, and epidemiology. Crit Rev Toxicol. 2003, 33 (3–4): 451-462.

  249. 249.

    Gersten O: The path traveled and the path ahead for the allostatic framework: A rejoinder on the framework's importance and the need for further work related to theory, data, and measurement. Soc Sci Med. 2008, 66 (3): 531-535.

Pre-publication history

  1. The pre-publication history for this paper can be accessed here:

Download references


This work was supported in part by NIH/NCCAM grant T32 AT01287.

Author information

Correspondence to Iris R Bell.

Additional information

Competing interests

Dr. Bell is a consultant to Standard Homeopathic/Hylands Inc, a U.S.-based manufacturer of homeopathic medicines. This company did not provide any financial support for the paper or its publication costs, and none of the homeopathic studies cited here utilized their products.

Authors' contributions

IRB performed the literature search on homeopathy and nanoparticles. IRB and MK jointly developed the complex adaptive systems aspects of the model. IRB wrote the first draft of the manuscript. MK revised the draft, identifying key concepts and organizing the manuscript around the assumptions and principles stated in the final draft. Both authors revised the manuscript in accord with reviewer feedback and approved the final manuscript.

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.

Authors’ original file for figure 1

Authors’ original file for figure 2

Authors’ original file for figure 3

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Bell, I.R., Koithan, M. A model for homeopathic remedy effects: low dose nanoparticles, allostatic cross-adaptation, and time-dependent sensitization in a complex adaptive system. BMC Complement Altern Med 12, 191 (2012).

Download citation


  • Homeopathy
  • Nanoparticles
  • Silica
  • Epitaxy
  • Hormesis
  • Cross adaptation
  • Time dependent sensitization
  • Metaplasticity
  • Allostasis
  • Complex adaptive system
  • Stress response network
  • Resilience
  • Nanomedicine